Patent Application
20220379292
This invention relates generally to olefin metathesis catalysts, to the preparation of such compounds, compositions comprising such compounds, methods of using such compounds, and the use of such compounds in the metathesis of olefins and in the synthesis of related olefin metathesis catalysts. The invention has utility in the fields of catalysis, organic synthesis, polymer chemistry, and in industrial applications such as oil and gas, fine chemicals and pharmaceuticals.
Since its discovery in the 1950s, olefin metathesis has emerged as a valuable synthetic method for the formation of carbon-carbon double bonds. Recent advances in applications to organic syntheses and polymer syntheses mostly rely on developments of well-defined olefin metathesis catalysts.
The technology of ruthenium metathesis catalysts has enabled the development of several research platforms including: ring opening metathesis polymerization (ROMP), ring opening cross metathesis (ROCM), cross metathesis (CM), ring closing metathesis (RCM).
First Generation Grubbs ruthenium olefin metathesis catalysts, such as: (PCy3)2(Cl)2Ru═CHPh, have been largely used in organic synthesis.
The incorporation of certain types of N-Heterocyclic Carbene (NHC) ligands played an essential role in the development of ruthenium metathesis catalysts, giving rise to the Second Generation Grubbs ruthenium olefin metathesis catalysts, such as: (IMesH2)(PCy3) (Cl)2Ru═CHPh, where IMesH2 is 1,3-dimesityl-4,5-dihydroimidazol-2-ylidene.
In order to exchange the phosphine on the Second Generation Grubbs ruthenium olefin metathesis catalysts, the Grubbs group reported in 2001 (Organometallics 2001, 20, 5314-5318) a method involving a precursor bearing two pyridine ligands: (IMesH2)(Cl)2(C5H5N)2Ru═CHPh. The labile pyridine ligands have allowed the preparation of diverse ruthenium olefin metathesis catalysts. However, the preparation of pyridine complexes, requires large quantities of expensive and malodorous reagents (pyridine), and difficult reaction conditions (negative ° C. temperatures) especially for industrial scale-up.
Therefore there is an ongoing need for efficient, high yield, high purity and ease in scaling up procedures for the synthesis of olefin metathesis catalysts, particularly Second Generation Grubbs ruthenium olefin metathesis catalysts.
To meet this need the inventors have discovered novel ruthenium olefin metathesis catalysts, bearing a sulfoxide ligand as described herein. The ruthenium olefin metathesis catalysts bearing sulfoxide labile ligands exhibit high stability and allow the ready synthesis of various Second Generation Grubbs ruthenium olefin metathesis catalysts in higher yield and with higher purity, compared to the existing procedures.
In one embodiment, the invention provides an olefin metathesis catalyst, represented by the structure of Formula (I)
wherein:
M is a Group 8 transition metal; generally M is ruthenium or osmium; typically M is ruthenium;
L1 and L2 are independently neutral electron donor ligands;
n is 0 or 1; typically n is 0;
m is 0, 1 or 2; typically m is 0;
Ra is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally Ra is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Ra is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl;
Rb is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally Rb is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Rb is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl; or Ra and Rb are linked together to form a five or a six heterocyclic membered ring with the sulfoxide group [—S(O)—];
X1 and X2 are independently anionic ligands; generally, X1 and X2 are independently halogen, trifluoroacetate, per-fluorophenols or nitrate; typically, X1 and X2 are independently Cl, Br, I or F;
R1 and R2 are independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; typically, R1 is hydrogen and R2 is unsubstituted phenyl, substituted phenyl or substituted 1-propenyl; or R1 and R2 are linked together to form an optionally substituted indenylidene.
In one embodiment, the invention provides a method of synthesizing the olefin metathesis catalysts of the invention.
In one embodiment, the invention provides a method of using the olefin metathesis catalysts of the invention in metathesis reactions.
In one embodiment, the invention provides a method of synthesizing a Second Generation Grubbs catalyst, using an olefin metathesis catalyst of the invention.
Other embodiments of the invention are described herein.
These and other aspects of the present invention will be apparent to one of skill in the art, in light of the following detailed description and examples. Furthermore, it is to be understood that none of the embodiments or examples of the invention described herein are to be interpreted as being limiting.
Unless otherwise indicated, the invention is not limited to specific reactants, substituents, catalysts, reaction conditions, or the like, as such may vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only and is not to be interpreted as being limiting.
As used in the specification and the appended claims, the singular forms “a,” “an,” and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to “an olefin” includes a single olefin as well as a combination or mixture of two or more olefins, reference to “a substituent” encompasses a single substituent as well as two or more substituents, and the like.
As used in the specification and the appended claims, the terms “for example”, “for instance”, “such as”, or “including” are meant to introduce examples that further clarify more general subject matter. Unless otherwise specified, these examples are provided only as an aid for understanding the invention, and are not meant to be limiting in any fashion.
In this specification and in the claims that follow, reference will be made to a number of terms, which shall be defined to have the following meanings:
The term “alkyl” as used herein refers to a linear, branched, or cyclic saturated hydrocarbon group typically although not necessarily containing 1 to 30 carbon atoms, generally containing 1 to 24 carbon atoms, typically 1 to 12 carbon atoms, such as methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, t-butyl, octyl, decyl, and the like, as well as cycloalkyl groups such as cyclopentyl, cyclohexyl and the like. The term “lower alkyl” intends an alkyl group of 1 to 6 carbon atoms, and the specific term “cycloalkyl” intends a cyclic alkyl group, typically having 4 to 8, preferably 5 to 7, carbon atoms. The term “substituted alkyl” refers to alkyl substituted with one or more substituent groups, and the terms “heteroatom-containing alkyl” and “heteroalkyl” refer to alkyl in which at least one carbon atom is replaced with a heteroatom. If not otherwise indicated, the terms “alkyl” and “lower alkyl” include linear, branched, cyclic, unsubstituted, substituted, and/or heteroatom-containing alkyl and lower alkyl, respectively.
The term “alkylene” as used herein refers to a divalent linear, branched, or cyclic alkyl group, where “alkyl” is as defined herein.
The term “alkenyl” as used herein refers to a linear, branched, or cyclic hydrocarbon group of 2 to 30 carbon atoms containing at least one double bond, such as ethenyl, n-propenyl, iso-propenyl, n-butenyl, iso-butenyl, octenyl, decenyl, tetradecenyl, hexadecenyl, eicosenyl, tetracosenyl, and the like. Generally “alkenyl” groups herein contain 2 to 24 carbon atoms, typically “alkenyl” groups herein contain 2 to 12 carbon atoms. The term “lower alkenyl” intends an “alkenyl” group of 2 to 6 carbon atoms, and the specific term “cycloalkenyl” intends a cyclic “alkenyl” group, typically having 5 to 8 carbon atoms. The term “substituted alkenyl” refers to “alkenyl” substituted with one or more substituent groups, and the terms “heteroatom-containing alkenyl” and “heteroalkenyl” refer to “alkenyl” in which at least one carbon atom is replaced with a heteroatom. If not otherwise indicated, the terms “alkenyl” and “lower alkenyl” include linear, branched, cyclic, unsubstituted, substituted, and/or heteroatom-containing “alkenyl” and lower “alkenyl”, respectively. The term “alkenyl” is used interchangeably with the term “olefin” herein.
The term “alkenylene” as used herein refers to a divalent linear, branched, or cyclic alkenyl group, where “alkenyl” is as defined herein.
The term “alkynyl” as used herein refers to a linear or branched hydrocarbon group of 2 to 30 carbon atoms containing at least one triple bond, such as ethynyl, n-propynyl, and the like. Generally “alkynyl” groups herein contain 2 to 24 carbon atoms; typical “alkynyl” groups described herein contain 2 to 12 carbon atoms. The term “lower alkynyl” intends an “alkynyl” group of 2 to 6 carbon atoms. The term “substituted alkynyl” refers to “alkynyl” substituted with one or more substituent groups, and the terms “heteroatom-containing alkynyl” and “heteroalkynyl” refer to “alkynyl” in which at least one carbon atom is replaced with a heteroatom. If not otherwise indicated, the terms “alkynyl” and “lower alkynyl” include linear, branched, unsubstituted, substituted, and/or heteroatom-containing “alkynyl” and lower “alkynyl” respectively.
The term “alkoxy” as used herein intends an alkyl group bound through a single, terminal ether linkage; that is, an “alkoxy” group can be represented as —O-alkyl where alkyl is as defined herein. A “lower alkoxy” group intends an alkoxy group containing 1 to 6 carbon atoms. Analogously, “alkenyloxy” and “lower alkenyloxy” respectively refer to an alkenyl and lower alkenyl group bound through a single, terminal ether linkage, and “alkynyloxy” and “lower alkynyloxy” respectively refer to an alkynyl and lower alkynyl group bound through a single, terminal ether linkage.
The term “aryl” as used herein, and unless otherwise specified, refers to an aromatic substituent containing a single aromatic ring or multiple aromatic rings that are fused together, directly linked, or indirectly linked (such that the different aromatic rings are bound to a common group such as a methylene or ethylene moiety). “Aryl” groups contain 5 to 30 carbon atoms, generally “aryl” groups contain 5 to 20 carbon atoms; and typically “aryl” groups contain 5 to 14 carbon atoms. Exemplary “aryl” groups contain one aromatic ring or two fused or linked aromatic rings, e.g., phenyl, naphthyl, biphenyl, diphenylether, diphenylamine, benzophenone, and the like. “Substituted aryl” refers to an aryl moiety substituted with one or more substituent groups; for example 2,4,6-trimethylphenyl (i.e., mesityl or Mes), 2-methyl-phenyl, 2,6-di-iso-propylphenyl (i.e., DIPP or DiPP), 2-isopropyl-phenyl (i.e., IPP, Ipp or ipp), 2-iso-propyl-6-methylphenyl (i.e., MIPP or Mipp or MiPP). The terms “heteroatom-containing aryl” and “heteroaryl” refer to “aryl” substituents in which at least one carbon atom is replaced with a heteroatom, as will be described in further detail infra.
The term “aryloxy” as used herein refers to an aryl group bound through a single, terminal ether linkage, wherein “aryl” is as defined herein. An “aryloxy” group can be represented as -0-aryl where aryl is as defined herein. Preferred “aryloxy” groups contain 5 to 24 carbon atoms, and particularly preferred “aryloxy” groups contain 5 to 14 carbon atoms. Examples of “aryloxy” groups include, without limitation, phenoxy, o-halo-phenoxy, m-halo-phenoxy, p-halo-phenoxy, o-methoxy-phenoxy, m-methoxy-phenoxy, p-methoxy-phenoxy, 2,4-dimethoxy-phenoxy, 3,4,5-trimethoxy-phenoxy, and the like.
The term “alkaryl” refers to an aryl group with an alkyl substituent, and the term “aralkyl” refers to an alkyl group with an aryl substituent, wherein “aryl” and “alkyl” are as defined herein. “Alkaryl” and “aralkyl” groups contain 6 to 30 carbon atoms; generally “alkaryl” and “aralkyl” groups contain 6 to 20 carbon atoms; and typically “alkaryl” and “aralkyl” groups contain 6 to 16 carbon atoms. “Alkaryl” groups include, for example, p-methylphenyl, 2,4-dimethylphenyl, p-cyclohexylphenyl, 2,7-dimethylnaphthyl, 7-cyclooctylnaphthyl, 3-ethyl-cyclopenta-1,4-diene, and the like. Examples of “aralkyl” groups include, without limitation, benzyl, 2-phenyl-ethyl, 3-phenyl-propyl, 4-phenyl-butyl, 5-phenyl-pentyl, 4-phenylcyclohexyl, 4-benzylcyclohexyl, 4-phenylcyclohexylmethyl, 4-benzylcyclohexylmethyl, and the like. The terms “alkaryloxy” and “aralkyloxy” refer to substituents of the formula —OR wherein R is “alkaryl” or “aralkyl”, respectively, as defined herein.
The term “acyl” refers to substituents having the formula —(CO)-alkyl, —(CO)-aryl, or —(CO)-aralkyl, and the term “acyloxy” refers to substituents having the formula —O(CO)-alkyl, —O(CO)-aryl, or —O(CO)-aralkyl, wherein “alkyl,” “aryl, and “aralkyl” are as defined herein.
The terms “cyclic” and “ring” refer to alicyclic or aromatic groups that may or may not be substituted and/or heteroatom containing, and that can be monocyclic, bicyclic, or polycyclic. The term “alicyclic” is used in the conventional sense to refer to an aliphatic cyclic moiety, as opposed to an aromatic cyclic moiety, and can be monocyclic, bicyclic, or polycyclic.
The terms “halo”, “halogen” and “halide” are used in the conventional sense to refer to a chloro, bromo, fluoro, or iodo substituent.
The term “hydrocarbyl” refers to univalent “hydrocarbyl” moieties containing 1 to 30 carbon atoms, typically containing 1 to 24 carbon atoms, specifically containing 1 to 12 carbon atoms, including linear, branched, cyclic, saturated, and unsaturated species, such as alkyl groups, alkenyl groups, aryl groups, and the like. The term “lower hydrocarbyl” intends a “hydrocarbyl” group of 1 to 6 carbon atoms, typically 1 to 4 carbon atoms, and the term “hydrocarbylene” intends a divalent “hydrocarbyl” moiety containing 1 to 30 carbon atoms, typically 1 to 24 carbon atoms, specifically 1 to 12 carbon atoms, including linear, branched, cyclic, saturated and unsaturated species. The term “lower hydrocarbylene” intends a “hydrocarbylene” group of 1 to 6 carbon atoms. “Substituted hydrocarbyl” refers to “hydrocarbyl” substituted with one or more substituent groups, and the terms “heteroatom-containing hydrocarbyl” and “heterohydrocarbyl” refer to hydrocarbyl in which at least one carbon atom is replaced with a heteroatom. Similarly, “substituted hydrocarbylene” refers to “hydrocarbylene” substituted with one or more substituent groups, and the terms “heteroatom-containing hydrocarbylene” and heterohydrocarbylene” refer to “hydrocarbylene” in which at least one carbon atom is replaced with a heteroatom. Unless otherwise indicated, the term “hydrocarbyl” and “hydrocarbylene” are to be interpreted as including substituted and/or heteroatom-containing “hydrocarbyl” and “hydrocarbylene” moieties, respectively.
The term “heteroatom-containing” as in a “heteroatom-containing hydrocarbyl group” refers to a hydrocarbon molecule or a hydrocarbyl molecular fragment in which one or more carbon atoms is replaced with an atom other than carbon, e.g., nitrogen, oxygen, sulfur, phosphorus or silicon, typically nitrogen, oxygen or sulfur. Similarly, the term “heteroalkyl” refers to an alkyl substituent that is heteroatom-containing, the term “heterocyclic” refers to a cyclic substituent that is heteroatom-containing, the terms “heteroaryl” and heteroaromatic” respectively refer to “aryl” and “aromatic” substituents that are heteroatom-containing, and the like. It should be noted that a “heterocyclic” group or compound may or may not be aromatic, and further that “heterocycles” can be monocyclic, bicyclic, or polycyclic as described herein with respect to the term “aryl.” Examples of heteroalkyl groups include alkoxyaryl, alkylsulfanyl-substituted alkyl, N-alkylated amino alkyl, and the like. Examples of heteroaryl substituents include pyrrolyl, pyrrolidinyl, pyridinyl, quinolinyl, indolyl, pyrimidinyl, imidazolyl, 1,2,4-triazolyl, tetrazolyl, etc.
By “substituted” as in “substituted hydrocarbyl,” “substituted alkyl,” “substituted aryl,” and the like, as alluded to in some of the aforementioned definitions, is meant that in the hydrocarbyl, alkyl, aryl, or other moiety, at least one hydrogen atom bound to a carbon (or other) atom is replaced with one or more non-hydrogen substituents. Examples of such substituents include, without limitation: functional groups referred to herein as “Fn,” such as halo, hydroxyl, sulfhydryl, C1-C24 alkoxy, C2-C24 alkenyloxy, C2-C24 alkynyloxy, C5-C24 aryloxy, C6-C24 aralkyloxy, C6-C24 alkaryloxy, acyl (including C2-C24 alkylcarbonyl (—CO-alkyl) and C6-C24 arylcarbonyl (—CO-aryl)), acyloxy (—O-acyl, including C2-C24 alkylcarbonyloxy (—O—CO-alkyl) and C6-C24 arylcarbonyloxy (—O—CO-aryl)), C2-C24 alkoxycarbonyl (—(CO)—O-alkyl), C6-C24 aryloxycarbonyl (—(CO)—O-aryl), halocarbonyl (—(CO)—X where X is halo), C2-C24 alkylcarbonato (—O—(CO)—O-alkyl), C6-C24 arylcarbonato (—O—(CO)—O-aryl), carboxyl (—COOH), carboxylato (—COO−), carbamoyl (—(CO)—NH2), mono-(C1-C24 alkyl)-substituted carbamoyl (—(CO)—NH(C1-C24 alkyl)), di-(C1-C24 alkyl)-substituted carbamoyl (—(CO)—N(C1-C24 alkyl)2), mono-(C5-C24 aryl)-substituted carbamoyl (—(CO)—NH-aryl), di-(C5-C24 aryl)-substituted carbamoyl (—(CO)—N(C5-C24 aryl)2), thiocarbamoyl (—(CS)—NH2), mono-(C1-C24 alkyl)-substituted thiocarbamoyl (—(CS)—NH(C1-C24 alkyl)), di-(C1-C24 alkyl)-substituted thiocarbamoyl (—(CS)—N(C1-C24 alkyl)2), mono-(C5-C24 aryl)-substituted thiocarbamoyl (—(CS)—NH-aryl), di-(C5-C24 aryl)-substituted thiocarbamoyl (—(CS)—N(C5-C24 aryl)2), carbamido (—NH—(CO)-NH2), cyano (—C≡N), cyanato (—O—C≡N), thiocyanato (—S—C≡N), formyl (—(CO)—H), thioformyl (—(CS)—H), amino (—NH2), mono-(C1-C24 alkyl)-substituted amino, di-(C1-C24 alkyl)-substituted amino, mono-(C5-C24 aryl)-substituted amino, di-(C5-C24 aryl)-substituted amino, (C1-C24 alkyl)(C5-C24 aryl)-substituted amino, (C2-C24 alkyl)-amido (—NH—(CO)-alkyl), (C6-C24 aryl)-amido (—NH—(CO)-aryl), imino (—CR═NH where R is hydrogen, C1-C24 alkyl, C5-C24 aryl, C6-C24 alkaryl, C6-C24 aralkyl, etc.), (C2-C20 alkyl)-imino (—CR═N(alkyl), where R is hydrogen, C1-C24 alkyl, C5-C24 aryl, C6-C24 alkaryl, C6-C24 aralkyl, etc.), arylimino (—CR═N(aryl), where R is hydrogen, C1-C20 alkyl, C5-C24 aryl, C6-C24 alkaryl, C6-C24 aralkyl, etc.), nitro (—NO2), nitroso (—NO), sulfo (—SO2—OH), sulfonato (—SO2—O−), (C1-C24 alkyl)-sulfanyl (—S-alkyl; also termed “alkylthio”), (C5-C24 aryl)-sulfanyl (—S-aryl; also termed “arylthio”), (C1-C24 alkyl)-sulfinyl (—(SO)-alkyl), (C5-C24 aryl)-sulfinyl (—(SO)-aryl), (C1-C24 alkyl)-sulfonyl (—SO2-alkyl),mono-(C1-C24 alkyl)-amino sulfonyl —SO2—N(H)alkyl), di-(C1-C24 alkyl)-aminosulfonyl —SO2-N(alkyl)2, (C5-C24 aryl)-sulfonyl (—SO2-aryl), boryl (—BH2), borono (—B(OH)2), boronato (—B(OR)2 where R is alkyl or other hydrocarbyl), phosphono (—P(O)(OH)2), phosphonato (—P(O)(O−)2), phosphinato (—P(O)(O−)), phospho (—PO2), and phosphino (—PH2); and the hydrocarbyl moieties C1-C24 alkyl (preferably C1-C12 alkyl, more preferably C1-C6 alkyl), C2-C24 alkenyl (preferably C2-C12 alkenyl, more preferably C2-C6 alkenyl), C2-C24 alkynyl (preferably C2-C12 alkynyl, more preferably C2-C6 alkynyl), C5-C24 aryl (preferably C5-C14 aryl), C6-C24 alkaryl (preferably C6-C16 alkaryl), and C6-C24 aralkyl (preferably C6-C16 aralkyl).
By “Grubbs-Hoveyda ligands”, is meant benzylidene ligands having a chelating alkyloxy group attached to the benzene ring at the ortho position.
By “sulfoxide group” is meant —[S(O)]—.
By “functionalized” as in “functionalized hydrocarbyl,” “functionalized alkyl,” “functionalized olefin,” “functionalized cyclic olefin,” and the like, is meant that in the hydrocarbyl, alkyl, olefin, cyclic olefin, or other moiety, at least one hydrogen atom bound to a carbon (or other) atom is replaced with one or more functional groups such as those described herein. The term “functional group” is meant to include any functional species that is suitable for the uses described herein. In particular, as used herein, a functional group would necessarily possess the ability to react with or bond to corresponding functional groups on a substrate surface.
In addition, the aforementioned functional groups may, if a particular group permits, be further substituted with one or more additional functional groups or with one or more hydrocarbyl moieties such as those specifically enumerated herein. Analogously, the herein-mentioned hydrocarbyl moieties can be further substituted with one or more functional groups or additional hydrocarbyl moieties such as those specifically enumerated.
“Optional” or “optionally” means that the subsequently described circumstance can or cannot occur, so that the description includes instances where the circumstance occurs and instances where it does not. For example, the phrase “optionally substituted” means that a non-hydrogen substituent can or cannot be present on a given atom, and, thus, the description includes structures wherein a non-hydrogen substituent is present and structures wherein a non-hydrogen substituent is not present.
In one embodiment, the invention provides an olefin metathesis catalyst, represented by the structure of Formula (I):
wherein
M is a Group 8 transition metal; generally M is ruthenium or osmium; typically M is ruthenium;
L1 and L2 are independently neutral electron donor ligands;
n is 0 or 1; typically n is 0;
m is 0, 1 or 2; typically m is 0;
R1 is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally Ra is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Ra is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl;
Rb is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally Rb is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Rb is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl;
X1 and X2 are independently anionic ligands; generally X1 and X2 are independently halogen, trifluoroacetate, per-fluorophenols or nitrate; typically X1 and X2 are independently Cl, Br, I or F;
R1 and R2 are independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; typically, R1 is hydrogen and R2 is unsubstituted phenyl, substituted phenyl or substituted 1-propenyl; or R1 and R2 are linked together to form an optionally substituted indenylidene.
In one embodiment, the invention provides an olefin metathesis catalyst, represented by the structure of Formula (I), wherein:
M is a Group 8 transition metal; generally M is ruthenium or osmium; typically M is ruthenium;
L1 and L2 are independently neutral electron donor ligands;
n is 0 or 1; typically n is 0;
m is 0, 1 or 2; typically m is 0;
Ra and Rb are linked together to form a five or a six heterocyclic membered ring with the sulfoxide group;
X1 and X2 are independently anionic ligands; generally X1 and X2 are independently halogen, trifluoroacetate, per-fluorophenols or nitrate; typically X1 and X2 are independently Cl, Br, I or F;
R1 and R2 are independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; typically, R1 is hydrogen and R2 is unsubstituted phenyl, substituted phenyl or substituted 1-propenyl; or R1 and R2 are linked together to form an optionally substituted indenylidene.
In one embodiment, the invention provides an olefin metathesis catalyst, represented by the structure of Formula (II):
wherein:
M is a Group 8 transition metal; generally M is ruthenium or osmium; typically M is ruthenium;
L1 is a carbene;
L2 is a neutral electron donor ligand;
n is 0 or 1; typically n is 0;
m is 0, 1 or 2; typically m is 0;
Ra is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally Ra is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Ra is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl;
Rb is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally Rb is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Rb is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl;
R1 and R2 are independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; typically, R1 is hydrogen and R2 is unsubstituted phenyl, substituted phenyl or substituted 1-propenyl; or R1 and R2 are linked together to form an optionally substituted indenylidene;
X3 and X4 are independently O or S; and
Rx, By, Rw and Rz are independently hydrogen, halogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally Rx, Ry, Rw and Rz are independently hydrogen, halogen, unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Rx, Ry, Rw and Rz are independently C1-C6 alkyl, hydrogen, unsubstituted phenyl, substituted phenyl or halogen; or Rx and Ry are linked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl; or Rw and Rz are linked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl; or Ry and Rw are linked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl.
In one embodiment, the invention provides an olefin metathesis catalyst, represented by the structure of Formula (II), wherein:
M is Ru;
L1 is a carbene;
n is 0;
m is 0;
Ra is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl;
Rb is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl; or
Ra and Rb are linked together to form a five or a six heterocyclic membered ring with the sulfoxide group;
R1 is hydrogen and R2 is unsubstituted phenyl, substituted phenyl or substituted 1-propenyl; or R1 and R2 are linked together to form an optionally substituted indenylidene;
X3 and X4 are independently S; and
Rx, Ry, Rw and Rz are independently hydrogen, halogen, unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Rx, Ry, Rw and Rz are independently C1-C6 alkyl, hydrogen, unsubstituted phenyl, substituted phenyl or halogen; or Rx and Ry are linked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl; or Rw and Rz are linked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl; or Ry and Rw are linked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl.
In one embodiment, the invention provides an olefin metathesis catalyst, represented by the structure of Formula (III),
wherein:
M is a Group 8 transition metal; generally M is ruthenium or osmium; typically M is ruthenium;
L2 is a neutral electron donor ligand;
n is 0 or 1; typically n is 0;
m is 0, 1 or 2; typically m is 0;
Ra is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally Ra is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Ra is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl;
Rb is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally Rb is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Rb is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl;
X1 and X2 are independently anionic ligands; generally X1 and X2 are independently halogen, trifluoroacetate, per-fluorophenols or nitrate; typically X1 and X2 are independently Cl, Br, I or F; and
R1 and R2 are independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; typically, R1 is hydrogen and R2 is unsubstituted phenyl, substituted phenyl or substituted 1-propenyl; or R1 and R2 are linked together to form an optionally substituted indenylidene;
X and Y are independently C, CR3a, N, O, S, or P; only one of X or Y can be C or CR3a; typically X and Y are independently N;
Q1, Q2, R3, R3a and R4 are independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, Q1, Q2, R3, R3a and R4 are optionally linked to X or Y via a linker such as unsubstituted hydrocarbylene, substituted hydrocarbylene, unsubstituted heteroatom-containing hydrocarbylene, substituted heteroatom-containing hydrocarbylene, or —(CO)—; typically Q1, Q2, R3, R3a and R4 are directly linked to X or Y; and
p is 0 when X is O or S, p is 1 when X is N, P or CR3a, and p is 2 when X is C; q is 0 when Y is O or S, q is 1 when Y is N, P or CR3a, and q is 2 when X is C.
In one embodiment, the invention provides an olefin metathesis catalyst, represented by the structure of Formula (III), wherein:
M is a Group 8 transition metal; generally M is ruthenium or osmium; typically M is ruthenium;
L2 is a neutral electron donor ligand;
n is 0 or 1; typically n is 0;
m is 0, 1 or 2; typically m is 0;
Ra and Rb are linked together to form a five or a six heterocyclic membered ring with the sulfoxide group;
X1 and X2 are independently anionic ligands; generally X1 and X2 are independently halogen, trifluoroacetate, per-fluorophenols or nitrate; typically X1 and X2 are independently Cl, Br, I or F; and
R1 and R2 are independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; typically, R1 is hydrogen and R2 is unsubstituted phenyl, substituted phenyl or substituted 1-propenyl; or R1 and R2 are linked together to form an optionally substituted indenylidene;
X and Y are independently C, CR3a, N, O, S, or P; only one of X or Y can be C or CR3a; typically X and Y are independently N;
Q1, Q2, R3, R3a and R4 are independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, Q1, Q2, R3, R3a and R4 are optionally linked to X or Y via a linker such as unsubstituted hydrocarbylene, substituted hydrocarbylene, unsubstituted heteroatom-containing hydrocarbylene, substituted heteroatom-containing hydrocarbylene, or —(CO)—; typically Q1, Q2, R3, R3a and R4 are directly linked to X or Y; and
p is 0 when X is O or S, p is 1 when X is N, P or CR3a, and p is 2 when X is C; q is 0 when Y is O or S, q is 1 when Y is N, P or CR3a, and q is 2 when X is C.
In one embodiment, the invention provides an olefin metathesis catalyst, represented by the structure of Formula (IV):
wherein:
M is a Group 8 transition metal;
L2 is a neutral electron donor ligand;
n is 0 or 1;
m is 0, 1 or 2;
Ra is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl;
Rb is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; or Ra and Rb are linked together to form a five or a six heterocyclic membered ring with the sulfoxide group;
X1 and X2 are independently anionic ligands;
R1 and R2 are independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; or R1 and R2 are linked together to form an optionally substituted indenylidene;
X and Y are independently C, CR3a or N; and only one of X or Y can be C or CR3a;
R3a is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl;
Q is a two-atom linkage having the structure —[CR11R12]s—[CR13R14]t— or —[CR11═CR13]—;
R11, R12, R13, and R14 are independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl;
“s” and “t” are independently 1 or 2;
R3 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; and
R4 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl.
In one embodiment of Formula (IV), any two or more of X1, X2, L2, R1, and R2 are optionally linked together to form a cyclic group, including bidentate or multidentate ligands; or any one or more of X1, X2, L2, R1, and R2 is/are optionally attached to a support.
In one embodiment, the invention provides an olefin metathesis catalyst, represented by the structure of Formula (IV):
M is a Group 8 transition metal; generally M is ruthenium or osmium; typically M is ruthenium;
L2 is a neutral electron donor ligand;
n is 0 or 1; typically n is 0;
m is 0, 1 or 2; typically m is 0;
Ra is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally Ra is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Ra is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl;
Rb is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally Rb is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Rb is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl;
X1 and X2 are independently anionic ligands; generally X1 and X2 are independently halogen, trifluoroacetate, per-fluorophenols or nitrate; typically X1 and X2 are independently Cl, Br, I or F;
R1 and R2 are independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; typically, R1 is hydrogen and R2 is unsubstituted phenyl, substituted phenyl or substituted 1-propenyl; or R1 and R2 are linked together to form an optionally substituted indenylidene;
X and Y are independently C, CR3a, or N; only one of X or Y can be C or CR3a; typically X and Y are independently N;
R3a is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl;
Q is a linker, typically unsubstituted hydrocarbylene, substituted hydrocarbylene, unsubstituted heteroatom-containing hydrocarbylene, or substituted heteroatom-containing hydrocarbylene; generally Q is a two-atom linkage having the structure —[CR11R12]s—[CR13R14]t— or —[CR11═CR13]—; typically Q is —[CR11R12]s—[CR13R14]t—, wherein R11, R12, R13, and R14 are independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; typically R11, R12, R13 and R14 are independently hydrogen, unsubstituted C1-C12 alkyl, substituted C1-C12 alkyl, unsubstituted C1-C12 heteroalkyl, substituted C1-C12 heteroalkyl, unsubstituted C5-C14 aryl, or substituted C5-C14 aryl; “s” and “t” are independently 1 or 2; typically “s” and “t” are independently 1; or any two of R11, R12, R13, and R14 are optionally linked together to form a substituted or unsubstituted, saturated or unsaturated ring structure;
R3 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R3 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted (C5-C24 aryl), (C5-C24 aryl) substituted with up to three substituents selected from unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide; typically, R3 is adamantyl, 2,4,6-trimethylphenyl, 2,6-di-iso-propylphenyl, 2-methyl-6-tert-butylphenyl, 2-iso-propyl-6-methylphenyl, 2-iso-propyl-phenyl, 2,6-di-ethylphenyl, 2-ethyl-6-methylphenyl, 2,4,6-trifluorophenyl, 3,5-di-tert-butylphenyl, 2,4-dimethylphenyl, 2,6-difluorophenyl, 2-fluoro-6-methylphenyl or 2-methyl-phenyl; and
R4 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R4 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted (C5-C24 aryl), or (C5-C24 aryl) substituted with up to three substituents selected from unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide; typically, R4 is, 2,4,6-trimethylphenyl, 2,6-di-iso-propylphenyl, 2-methyl-6-tert-butylphenyl, 2-iso-propyl-6-methylphenyl, 2-iso-propyl-phenyl, 2,6-di-ethylphenyl, 2-ethyl-6-methylphenyl, 2,4,6-trifluorophenyl, 3,5-di-tert-butylphenyl, 2,4-dimethylphenyl, 2,6-difluorophenyl, 2-fluoro-6-methylphenyl or 2-methyl-phenyl; or when X is CR3a, then R3a and R4 can from together a five to ten membered cycloalkyl or heterocyclic ring, with the carbon atom to which they are attached.
In one embodiment, the invention provides an olefin metathesis catalyst, represented by the structure of Formula (IV), wherein:
M is a Group 8 transition metal; generally M is ruthenium or osmium; typically M is ruthenium;
L2 is a neutral electron donor ligand;
n is 0 or 1; typically n is 0;
m is 0, 1 or 2; typically m is 0;
Ra and Rb are linked together to form a five or a six heterocyclic membered ring with the sulfoxide group;
X1 and X2 are independently anionic ligands; generally X1 and X2 are independently halogen, trifluoroacetate, per-fluorophenols or nitrate; typically X1 and X2 are independently Cl, Br, I or F;
R1 and R2 are independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; typically, R1 is hydrogen and R2 is unsubstituted phenyl, substituted phenyl or substituted 1-propenyl; or R1 and R2 are linked together to form an optionally substituted indenylidene;
X and Y are independently C, CR3a, or N; only one of X or Y can be C or CR3a; typically X and Y are independently N;
R3a is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl;
Q is a linker, typically unsubstituted hydrocarbylene, substituted hydrocarbylene, unsubstituted heteroatom-containing hydrocarbylene, or substituted heteroatom-containing hydrocarbylene; generally Q is a two-atom linkage having the structure —[CR11R12]s—[CR13R14]t— or —[CR11═CR13]—; typically Q is —[CR11R12]s—[CR13R14]t—, wherein R11, R12, R13, and R14 are independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; typically R11, R12, R13 and R14 are independently hydrogen, unsubstituted C1-C12 alkyl, substituted C1-C12 alkyl, unsubstituted C1-C12 heteroalkyl, substituted C1-C12 heteroalkyl, unsubstituted C5-C14 aryl, or substituted C5-C14 aryl; “s” and “t” are independently 1 or 2; typically “s” and “t” are independently 1; or any two of R11, R12, R13, and R14 are optionally linked together to form a substituted or unsubstituted, saturated or unsaturated ring structure;
R3 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R3 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted (C5-C24 aryl), (C5-C24 aryl) substituted with up to three substituents selected from unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide; typically, R3 is adamantyl, 2-iso-propyl-phenyl, 2,4,6-trimethylphenyl, 2,6-di-iso-propylphenyl, 2-iso-propyl-6-methylphenyl or 2-methyl-phenyl; and
R4 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R4 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted (C5-C24 aryl), or (C5-C24 aryl) substituted with up to three substituents selected from unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide; typically, R4 is 2,4,6-trimethylphenyl, 2-iso-propyl-phenyl, 2,6-di-iso-propylphenyl , 2-iso-propyl-6-methylphenyl, or 2-methyl-phenyl.
In one embodiment, the invention provides an olefin metathesis catalyst, represented by the structure of Formula (IV), wherein:
M is Ru;
n is 0;
m is 0;
Ra is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; Ra is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl;
Rb is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; Rb is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; or Ra and Rb are linked together to form a five or a six heterocyclic membered ring with the sulfoxide group;
X1 and X2 are independently halogen, trifluoroacetate, per-fluorophenols or nitrate; generally X1 and X2 are independently Cl, Br, I or F;
R1 is hydrogen;
R2 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; or R1 and R2 are linked together to form an optionally substituted indenylidene;
X and Y are independently N;
Q is a two-atom linkage having the structure —[CR11R12]s—[CR13R14]t—; R11, R12, R13, and R14 are independently hydrogen; “s” and “t” are independently 1; therefore, Q is —(CH2—CH2)—;
R3 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally R3 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl, or C5-C24 aryl substituted with up to three substituents selected from: unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide; and
R4 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally R4 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl, or C5-C24 aryl substituted with up to three substituents selected from: unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide.
Therefore, the olefin metathesis catalyst of Formula (IV), can be represented by the structure of Formula (V)
wherein:
R1 is hydrogen;
R2 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; typically R2 is unsubstituted phenyl, substituted phenyl or substituted 1-propenyl; or R1 and R2 are linked together to form an optionally substituted indenylidene;
Ra is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally Ra is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Ra is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl;
Rb is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally Rb is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Rb is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl;
X1 and X2 are independently halogen, trifluoroacetate, per-fluorophenols or nitrate; generally X1 and X2 are independently Cl, Br, I or F; typically X1 and X2 are independently Cl;
R3 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R3 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl, C5-C24 aryl substituted with up to three substituents selected from unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide; typically, R3 is adamantyl, 2,4,6-trimethylphenyl, 2,6-di-iso-propylphenyl, 2-iso-propyl-6-methylphenyl, 2-iso-propyl-phenyl or 2-methyl-phenyl; and
R4 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R4 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl, or C5-C24 aryl substituted with up to three substituents selected from unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide; typically, R4 is 2,4,6-trimethylphenyl, 2-iso-propyl-phenyl, 2,6-di-iso-propylphenyl, 2-iso-propyl-6-methylphenyl or 2-methyl-phenyl.
In one embodiment, the invention provides an olefin metathesis catalyst represented by the structure of Formula (V), wherein:
R1 is hydrogen;
R2 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; typically R2 is unsubstituted phenyl, substituted phenyl or substituted 1-propenyl; or R1 and R2 are linked together to form an optionally substituted indenylidene;
Ra and Rb are linked together to form a five or a six heterocyclic membered ring with the sulfoxide group; typically, Ra and Rb are linked together to form a tetrahydrothiophene oxide;
X1 and X2 are independently halogen, trifluoroacetate, per-fluorophenols or nitrate; generally X1 and X2 are independently Cl, Br, I or F; typically X1 and X2 are independently Cl;
R3 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R3 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl, C5-C24 aryl substituted with up to three substituents selected from unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide; typically, R3 is adamantyl, 2,4,6-trimethylphenyl, 2,6-di-iso-propylphenyl, 2-iso-propyl-6-methylphenyl, 2-iso-propyl-phenyl or 2-methyl-phenyl; and
R4 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R4 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl, or C5-C24 aryl substituted with up to three substituents selected from unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide; typically, R4 is 2,4,6-trimethylphenyl, 2-iso-propyl-phenyl, 2,6-di-iso-propylphenyl, 2-iso-propyl-6-methylphenyl or 2-methyl-phenyl.
In one embodiment, the invention provides an olefin metathesis catalyst represented by the structure of Formula (V), wherein:
R1 is hydrogen;
R2 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; or R1 and R2 are linked together to form an optionally substituted indenylidene;
Ra is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl;
Rb is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; or Ra and Rb are linked together to form a five or a six heterocyclic membered ring with the sulfoxide group;
X1 and X2 are independently halogen;
R3 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl, C5-C24 aryl substituted with up to three substituents selected from C1-C20 alkyl, substituted unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide; and
R4 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl, or C5-C24 aryl substituted with up to three substituents selected unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide.
In one embodiment, the invention provides an olefin metathesis catalyst represented by the structure of Formula (V), wherein:
R1 is hydrogen;
R2 is unsubstituted phenyl, substituted phenyl or substituted 1-propenyl;
Ra is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, or phenyl;
Rb is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, or phenyl; or Ra and Rb are linked together to form a tetrahydrothiophene oxide;
X1 and X2 are independently Cl; and
R3 is adamantyl, 2,4,6-trimethylphenyl, 2,6-di-iso-propylphenyl , 2-iso-propyl-6-methylphenyl, 2-iso-propyl-phenyl or 2-methyl-phenyl; and
R4 is 2,4,6-trimethylphenyl , 2,6-di-iso-propylphenyl, 2-iso-propyl-6-methylphenyl, 2-iso-propyl-phenyl or 2-methyl-phenyl.
In one embodiment, the invention provides an olefin metathesis catalyst represented by the structure of Formula (V), wherein:
R1 is hydrogen; R2 is phenyl, 2-iso-propoxy-phenyl (i.e.
), or 2-methyl-1-propenyl (i.e —CH═C(CH3)2 or
); or R1 and R2 are linked together to form 3-phenylinden-1-ylidene (i.e.
);
Ra is hydrogen, methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, or phenyl;
Rb is hydrogen, methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, or phenyl;
X1 and X2 are independently Cl;
R3 is phenyl, 2,4,6-trimethylphenyl, 2,6-di-iso-propylphenyl, adamantyl, 2-iso-propyl-phenyl, 2-methyl-phenyl or 2-isopropyl-6-methyl phenyl; and
R4 is phenyl, 2,4,6-trimethylphenyl, 2,6-di-iso-propylphenyl, 2-iso-propyl-phenyl, 2-methyl-phenyl or 2-isopropyl-6-methyl phenyl.
In one embodiment, the invention provides an olefin metathesis catalyst represented by the structure of Formula (V), wherein:
R1 is hydrogen; R2 is phenyl, 2-iso-propoxy-phenyl, or 2-methyl-1-propenyl; or R1 and R2 are linked together to form 3-phenylinden-1-ylidene;
Ra and Rb are linked together to form with the sulfoxide group a tetrahydrothiophene oxide;
X1 and X2 are independently Cl;
R3 is phenyl, 2,4,6-trimethylphenyl, 2,6-di-iso-propylphenyl, adamantyl, 2-iso-propyl-phenyl, 2-methyl-phenyl or 2-isopropyl-6-methyl phenyl; and
R4 is phenyl, 2,4,6-trimethylphenyl, 2,6-di-iso-propylphenyl, 2-iso-propyl-phenyl, 2-methyl-phenyl or 2-isopropyl-6-methyl phenyl.
In one embodiment, the invention provides an olefin metathesis catalyst represented by the structure of Formula (V), wherein:
R1 and R2 are linked together to form 3-phenylinden-1-ylidene;
Ra is methyl;
Rb is methyl;
X1 and X2 are independently Cl;
R3 is 2,4,6-trimethylphenyl; and
R4 is 2,4,6-trimethylphenyl.
Non-limiting examples of olefin metathesis catalysts represented by the structure of Formula (V) are described in Table (1), wherein X1 is Cl and X2 is Cl.
wherein: Mes is
adamantyl is
2-Me-C6H5 is
Me is methyl, n-Bu is butyl [CH3—(CH2)3—], Ph is phenyl, and
is [—(CH2)4—].
In one embodiment, the invention provides an olefin metathesis catalyst represented by the structure of Formula (IV), wherein:
M is Ru;
n is 0;
m is 0;
Ra is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; Ra is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl;
Rb is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; Rb is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; or Ra and Rb are linked together to form a five or a six heterocyclic membered ring with the sulfoxide group;
X1 and X2 are independently halogen, trifluoroacetate, per-fluorophenols or nitrate; generally X1 and X2 are independently Cl, Br, I or F;
R1 is hydrogen;
R2 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; or R1 and R2 are linked together to form an optionally substituted indenylidene;
X and Y are independently N;
Q is a two-atom linkage having the structure —[CR11═CR13]—; R11 and R13 are hydrogen; therefore, Q is —(CH═CH)—;
R3 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally R3 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl, or C5-C24 aryl substituted with up to three substituents selected from: unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide; and
R4 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally R4 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl, or C5-C24 aryl substituted with up to three substituents selected from: unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide.
Therefore, the olefin metathesis catalyst of Formula (IV), can be represented by the structure of Formula (VI)
wherein:
R1 is hydrogen;
R2 is unsubstituted phenyl, substituted phenyl or substituted 1-propenyl; or R1 and R2 are linked together to form an optionally substituted indenylidene;
Ra is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; Ra is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl;
Rb is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; Rb is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; or Ra and Rb are linked together to form a five or a six heterocyclic membered ring with the sulfoxide group;
X1 and X2 are independently halogen, trifluoroacetate, per-fluorophenols or nitrate; X1 and X2 are independently Cl, Br, I or F; typically, X1 and X2 are independently Cl;
R3 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R3 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl, C5-C24 aryl substituted with up to three substituents selected from unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C6-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide; typically, R3 is adamantyl, 2,4,6-trimethylphenyl, 2,6-di-iso-propylphenyl, 2-iso-propyl-6-methylphenyl, 2-iso-propyl-phenyl or 2-methyl-phenyl; and
R4 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R4 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl, or C5-C24 aryl substituted with up to three substituents selected from unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide; typically, R4 is 2,4,6-trimethylphenyl, 2-iso-propyl-phenyl, 2,6-di-iso-propylphenyl, 2-iso-propyl-6-methylphenyl or 2-methyl-phenyl.
In one embodiment, the invention provides an olefin metathesis catalyst represented by the structure of Formula (VI), wherein:
R1 is hydrogen; R2 is phenyl, 2-iso-propoxy-phenyl, or 2-methyl-1-propenyl; or R1 and R2 are linked together to form 3-phenylinden-1-ylidene;
Ra is hydrogen, methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, or phenyl;
Rb is hydrogen, methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, or phenyl;
X1 and X2 are independently Cl; and
R3 is adamantyl, 2,4,6-trimethylphenyl, 2,6-di-iso-propylphenyl, 2-iso-propyl-6-methylphenyl or 2-methyl-phenyl; and
R4 is 2,4,6-trimethylphenyl, 2,6-di-iso-propylphenyl, 2-iso-propyl-6-methylphenyl or 2-methyl-phenyl.
In one embodiment, the invention provides an olefin metathesis catalyst represented by the structure of Formula (VI), wherein:
Ra and Rb are linked together to form a five or a six heterocyclic membered ring with the sulfoxide group;
Non-limiting examples of olefin metathesis catalysts represented by the structure of Formula (VI) are described in Table (2), wherein X1 is Cl and X2 is Cl.
In one embodiment, the invention provides an olefin metathesis catalyst represented by the structure of Formula (IV), wherein:
M is Ru;
n is 0;
m is 0;
Ra is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally Ra is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Ra is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl;
Rb is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally Rb is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Rb is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl; or Ra and Rb are linked together to form a five or a six heterocyclic membered ring with the sulfoxide group;
X1 and X2 are independently halogen, trifluoroacetate, per-fluorophenols or nitrate; typically X1 and X2 are independently Cl, Br, I or F;
R1 is hydrogen;
R2 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; typically, R1 is hydrogen and R2 is unsubstituted phenyl, substituted phenyl or substituted 1-propenyl; or R1 and R2 are linked together to form an optionally substituted indenylidene;
Y is N;
X is CR3a;
R3a is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; or R3a and R4 can from together a five to ten membered cycloalkyl or heterocyclic ring, with the carbon atom to which they are attached;
Q is a two-atom linkage having the structure —[CR11R12]s—[CR13R14]t—; wherein R11, R12, R13, and R14 are independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; typically R11, R12, R13 and R14 are independently hydrogen, unsubstituted C1-C12 alkyl, substituted C1-C12 alkyl, unsubstituted C1-C12 heteroalkyl, substituted C1-C12 heteroalkyl, unsubstituted C5-C14 aryl, or substituted C5-C14 aryl; “s” and “t” are independently 1;
R3 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R3 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted (C5-C24 aryl), (C5-C24 aryl) substituted with up to three substituents selected from unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide; and
R4 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R4 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted (C5-C24 aryl), or (C5-C24 aryl) substituted with up to three substituents selected from unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide; or R3a and R4 can from together a five to ten membered cycloalkyl or heterocyclic ring, with the carbon atom to which they are attached.
Therefore, the olefin metathesis catalyst of Formula (IV), can be represented by the structure of Formula (VII)
wherein:
Ra is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally Ra is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Ra is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl;
Rb is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally Rb is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Rb is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl; or Ra and Rb are linked together to form a five or a six heterocyclic membered ring with the sulfoxide group;
X1 and X2 are independently halogen, trifluoroacetate, per-fluorophenols or nitrate; generally X1 and X2 are independently Cl, Br, I or F; typically X1 and X2 are independently Cl;
R3 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R3 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl, C5-C24 aryl substituted with up to three substituents selected from unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide; typically, R3 is adamantyl, 2,4,6-trimethylphenyl, 2,6-di-iso-propylphenyl, 2-methyl-6-tert-butylphenyl, 2-iso-propyl-6-methylphenyl, 2-iso-propyl-phenyl, 2,6-di-ethylphenyl, 2-ethyl-6-methylphenyl or 2-methyl-phenyl;
R11, R12, R13 and R14 are independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R11, R12, R13 and R14 are independently hydrogen, unsubstituted C1-C12 alkyl, substituted C1-C12 alkyl, unsubstituted C4-C12 cycloalkyl, substituted C4-C12 cycloalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 heteroaralkyl or substituted C6-C24 heteroaralkyl; typically, R11 and R12 are independently methyl and R13 and R14 are independently hydrogen;
R3a is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R3a is unsubstituted C1-C12 alkyl, substituted C1-C12 alkyl, unsubstituted C4-C12 cycloalkyl, substituted C4-C12 cycloalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 heteroaralkyl or substituted C6-C24 heteroaralkyl; typically R3a is methyl, ethyl, n-propyl, or phenyl; or together with R4 can form a five to ten membered cycloalkyl or heterocyclic ring, with the carbon atom to which they are attached; and
R4 is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R4 is unsubstituted C1-C12 alkyl, substituted C1-C12 alkyl, unsubstituted C4-C12 cycloalkyl, substituted C4-C12 cycloalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 heteroaralkyl or substituted C6-C24 heteroaralkyl; typically R4 is methyl, ethyl, n-propyl, or phenyl; or together with R3a can form a five- to ten-membered cycloalkyl or heterocyclic ring, with the carbon atom to which they are attached.
In one embodiment, the invention provides an olefin metathesis catalyst represented by the structure of Formula (VII), wherein:
R1 is hydrogen; R2 is phenyl, 2-iso-propoxy-phenyl, or 2-methyl-1-propenyl; or R1 and R2 are linked together to form 3-phenylinden-1-ylidene;
Ra is hydrogen, methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, or phenyl;
Rb is hydrogen, methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, or phenyl;
X1 and X2 are independently Cl; and
R3 is 2,4,6-trimethylphenyl, 2,6-di-iso-propylphenyl, 2-iso-propyl-phenyl, 2-iso-propyl-6-methylphenyl, 2,6-di-ethylphenyl, 2-methyl-6-tert-butylphenyl, 2-ethyl-6-methylphenyl or 2-methyl-phenyl;
R11 and R12 are independently methyl;
R13 and R14 are independently hydrogen;
R3a is methyl, ethyl, n-propyl, or phenyl; and
R4 is methyl, ethyl, n-propyl, or phenyl; or R13a and R4 form together a five-, six-, or ten-membered cycloalkyl or heterocycle ring, with the carbon atom to which they are attached.
Non-limiting examples of olefin metathesis catalysts represented by the structure of Formula (VII) are described in Table (3), wherein X1 is Cl, X2 is Cl, R11 is methyl, R12 is methyl, R13 is hydrogen and R14 is hydrogen.
wherein EMP is
In another embodiment of Formula (IV), the invention provides an olefin metathesis catalyst wherein:
M is a Group 8 transition metal; generally M is ruthenium or osmium; typically M is ruthenium;
L2 is a neutral electron donor ligand;
n is 0 or 1; typically n is 0;
m is 0, 1 or 2; typically m is 0;
Ra is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally Ra is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Ra is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl;
Rb is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally Rb is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Rb is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl; or Ra and Rb are linked together to form a five or a six heterocyclic membered ring with the sulfoxide group;
X and Y are independently C, CR3a or N; and only one of X or Y can be C or CR3a;
R3a is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl;
Q is a two-atom linkage having the structure —[CR11R12]s—[CR13R14]t— or —[CR11═CR13]—;
R11, R12, R13, and R14 are independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl;
“s” and “t” are independently 1 or 2;
R3 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl;
R4 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl;
R1 and R2 are independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; or R1 and R2 are linked together to form an optionally substituted indenylidene:
X3 and X4 are independently O or S; and
Rx, Ry, Rw and Rz are independently hydrogen, halogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; or Rx and Ry are linked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl; or Rw and Rz are linked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl; or Ry and Rw are linked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl.
In another embodiment of Formula (IV), the invention provides an olefin metathesis catalyst wherein:
M is Ru;
n is 0;
m is 0;
Ra is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Ra is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl;
Rb is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Rb is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl; or Ra and Rb are linked together to form a five or a six heterocyclic membered ring with the sulfoxide group;
X and Y are independently N;
Q is a two-atom linkage having the structure —[CR11R12]s—[CR13R14]t—;
R11, R12, R13, and R14 are independently C1-C6 alkyl, or hydrogen; generally R11 is hydrogen or methyl, R12 is hydrogen or methyl, R13 is hydrogen and R14 is hydrogen; typically R11, R12, R13, and R14 are independently hydrogen;
“s” and “t” are independently 1;
R3 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl;
R4 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl;
R1 is hydrogen and R2 is unsubstituted phenyl, substituted phenyl or substituted 1-propenyl; or R1 and R2 are linked together to form an optionally substituted indenylidene;
X3 and X4 are independently S; and
Rx, Ry, Rw and Rz are independently C1-C6 alkyl, hydrogen, halogen, unsubstituted phenyl or substituted phenyl; generally Rx is methyl, hydrogen or Cl, Ry is hydrogen, Rw is hydrogen, Rz is Cl, t-butyl, hydrogen or phenyl; or Rx and Ry are linked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl; or Rw and Rz are linked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl; or Ry and Rw are linked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl.
Therefore, the olefin metathesis catalyst of Formula (IV), can be represented by the structure of Formula (VIII)
wherein:
Ra is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Ra is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl;
Rb is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Rb is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl; or Ra and Rb are linked together to form a five or a six heterocyclic membered ring with the sulfoxide group;
R3 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl, C5-C24 aryl substituted with up to three substituents selected from unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide; typically, R3 is adamantyl, 2,4,6-trimethylphenyl, 2,6-di-iso-propylphenyl, 2-methyl-6-tert-butylphenyl, 2-iso-propyl-6-methylphenyl, 2-iso-propyl-phenyl, 2,6-di-ethylphenyl, 2-ethyl-6-methylphenyl, 2,4,6-trifluorophenyl, 2,6-difluorophenyl, 3,5-di-tert-butylphenyl, 2,4-dimethylphenyl or 2-methyl-phenyl;
R4 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl, C5-C24 aryl substituted with up to three substituents selected from unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide; typically, R4 is 2,4,6-trimethylphenyl, 2,6-di-iso-propylphenyl, 2-methyl-6-tert-butylphenyl, 2-iso-propyl-6-methylphenyl, 2-iso-propyl-phenyl, 2,6-di-ethylphenyl, 2-ethyl-6-methylphenyl, 2,4,6-trifluorophenyl, 2,6-difluorophenyl, 3,5-di-tert-butylphenyl, 2,4-dimethylphenyl or 2-methyl-phenyl;
R1 is hydrogen and R2 is unsubstituted phenyl, substituted phenyl or substituted 1-propenyl; or R1 and R2 are linked together to form an optionally substituted indenylidene;
R11, R12, R13, and R14 are independently C1-C6 alkyl, or hydrogen; generally R11 is hydrogen or methyl, R12 is hydrogen or methyl, R13 is hydrogen and R14 is hydrogen; typically R11, R12, R13, and R14 are independently hydrogen;
Rx, Ry, Rw and Rz are independently C1-C6 alkyl, hydrogen, halogen, unsubstituted phenyl or substituted phenyl; generally Rx is methyl, hydrogen or Cl, Ry is hydrogen, Rw is hydrogen, Rz is Cl, t-butyl, hydrogen or phenyl; or Rx and Ry are linked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl; or Rw and Rz are linked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl; or Ry and Rw are linked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl.
In one embodiment, the invention provides an olefin metathesis catalyst represented by the structure of Formula (VIII), wherein:
Ra is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl;
Rb is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl; or Ra and Rb are linked together to form a five or a six heterocyclic membered ring with the sulfoxide group;
R3 is adamantyl, 2,4,6-trimethylphenyl, 2,6-di-iso-propylphenyl, 2-methyl-6-tert-butylphenyl, 2-iso-propyl-6-methylphenyl, 2-iso-propyl-phenyl, 2,6-di-ethylphenyl, 2-ethyl-6-methylphenyl, 2,4,6-trifluorophenyl, 3,5-di-tert-butylphenyl, 2,4-dimethylphenyl, 2,6-difluorophenyl or 2-methyl-phenyl;
R4 is 2,4,6-trimethylphenyl, 2,6-di-iso-propylphenyl, 2-methyl-6-tert-butylphenyl, 2-iso-propyl-6-methylphenyl, 2-iso-propyl-phenyl, 2,6-di-ethylphenyl, 2-ethyl-6-methylphenyl, 2,4,6-trifluorophenyl, 3,5-di-tert-butylphenyl, 2,4-dimethylphenyl, 2,6-difluorophenyl or 2-methyl-phenyl;
R1 is hydrogen and R2 is unsubstituted phenyl, substituted phenyl or substituted 1-propenyl; or R1 and R2 are linked together to form an optionally substituted indenylidene;
R11 is hydrogen or methyl, R12 is hydrogen or methyl, R13 is hydrogen and R14 is hydrogen; typically R11, R12, R13, and R14 are independently hydrogen;
Rx is methyl, hydrogen or Cl, Ry is hydrogen, Rw is hydrogen, Rz is Cl, t-butyl, hydrogen or phenyl; or Rx and Ry are linked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl; or Rw and Rz are linked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl; or Ry and Rw are linked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl.
Non-limiting examples of olefin metathesis catalysts represented by the structure of Formula (VIII) are described in Table (4), wherein Ra is methyl, Rb is methyl, R11 is hydrogen, R12 is hydrogen, R13 is hydrogen, R14 is hydrogen, Ry is hydrogen and Rw is hydrogen.
The present invention also concerns processes for synthesizing the olefin metathesis catalysts of the invention. The olefin metathesis catalysts according to the invention can be prepared analogously to conventional methods as understood by the person skilled in the art of synthetic organic chemistry. For example, synthetic Scheme 1, set forth below, illustrates how the compounds according to the invention can be made.
In a typical procedure, an olefin metathesis catalyst of general Formula (A) is reacted at room temperature with tosyl chloride (TsCl) and an excess of sulfoxide derivative (RaRbSO) to produce an olefin metathesis catalyst of general Formula (V), wherein:
R1 is hydrogen;
R2 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally R2 is unsubstituted phenyl, substituted phenyl or substituted 1-propenyl; or R1 and R2 are linked together to form an optionally substituted indenylidene; typically R2 is phenyl, 2-iso-propoxy-phenyl or 2-methyl-1-propenyl; or R1 and R2 are linked together to form 3-phenyl-1-indenylidene;
X1 and X2 are independently halogen, trifluoroacetate, per-fluorophenols or nitrate; generally X1 and X2 are independently Cl, Br, I or F; typically X1 and X2 are independently Cl;
R3 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R3 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl, or C5-C24 aryl substituted with up to three substituents selected from: unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide; typically, R3 is adamantyl, 2,4,6-trimethylphenyl, 2,6-di-iso-propylphenyl, 2-iso-propyl-6-methylphenyl, 2-iso-propyl-phenyl or 2-methyl-phenyl;
R4 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R4 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl, or C5-C24 aryl substituted with up to three substituents selected from: unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide; typically, R4 is 2,4,6-trimethylphenyl, 2,6-di-iso-propylphenyl, 2-iso-propyl-6-methylphenyl, 2-iso-propyl-phenyl or 2-methyl-phenyl;
Ra is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally Ra is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Ra is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl;
Rb is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally Rb is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Rb is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl; or Ra and Rb are linked together to form a five or a six heterocyclic membered ring with the sulfoxide group; and
Rj, Rt, and Ro are each independently substituted C5-C24 aryl, unsubstituted C5-C24 aryl or substituted C1-C10 alkyl, unsubstituted C1-C10 alkyl; generally Rj, Rt, and Ro are each independently unsubstituted C5-C24 aryl; typically Rj, Rt, and Ro are each independently phenyl.
In another embodiment, the invention concerns methods of using the olefin metathesis catalysts of the invention, in the synthesis of related olefin metathesis catalysts. The ruthenium olefin metathesis catalysts bearing sulfoxide labile ligands of the invention are excellent precursors for various Second Generation Grubbs ruthenium olefin metathesis catalysts. The Second Generation Grubbs ruthenium olefin metathesis catalysts synthesized during these procedures are obtained in higher yield and with higher purity, which presents an advantage compared to the existing synthetic procedures.
For example, synthetic Scheme 2, set forth below, illustrates how olefin metathesis catalysts of Formula (F) can be synthesizing from an olefin metathesis catalyst of Formula (IV).
In a typical procedure, as shown in Scheme 2, the sulfoxide ligand of the olefin metathesis catalyst represented by Formula (IV) can be exchanged with “L” ligand, which is a neutral electron donor. R1, R2, R3, R4, R, X1, X2, M, Q, n, m, Ra, Rb and L2 are as defined herein. “L” is selected from the group consisting of sulphonated phosphine, phosphite, phosphinite, phosphonite, ether, amine, carbonyl, nitrosyl, pyridine, thioether, Grubbs-Hoveyda ligands, trimethylphosphine (PMe3), triethylphosphine (PEt3), tri-n-butylphosphine (PBu3), tri(ortho-tolyl)phosphine (P-o-tolyl3), tri-tert-butylphosphine (P-tert-Bu3), tricyclopentylphosphine (PCp3), tricyclohexylphosphine (PCy3), triisopropylphosphine (P-i-Pr3), trioctylphosphine (POct3), triisobutylphosphine, (P-i-Bu3), triphenylphosphine (PPh3), tri(pentafluorophenyl)phosphine (P(C6F5)3), methyldiphenylphosphine (PMePh2), dimethylphenylphosphine (PMe2Ph), diethylphenylphosphine (PEt2Ph), phosphabicycloalkane (e.g., monosubstituted 9-phosphabicyclo-[3.3.1]nonane, monosubstituted 9-phosphabicyclo[4.2.1]nonane, cyclohexylphoban, isopropylphoban, ethylphoban, methylphoban, butylphoban, pentylphoban), pyridine, 3-bromopyridine, 4-bromopyridine, 3,5-dibromopyridine, 2,4,6-tribromopyridine, 2,6-dibromopyridine, 3-chloropyridine, 4-chloropyridine, 3,5-dichloropyridine, 2,4,6-trichloropyridine, 2,6-dichloropyridine, 4-iodopyridine, 3,5-diiodopyridine, 3,5-dibromo-4-methylpyridine, 3,5-dichloro-4-methylpyridine, 3,5-dimethyl-4-bromopyridine, 3,5-dimethylpyridine, 4-methylpyridine, 3,5-di-iso-propylpyridine, 2,4,6-trimethylpyridine, 2,4,6-triisopropylpyridine, 4-(tert-butyl)pyridine, 4-phenylpyridine, 3,5-diphenylpyridine, 3,5-dichloro-4-phenylpyridine, bipyridine, pyridazine, pyrimidine, bipyridamine, pyrazine, 1,3,5-triazine, 1,2,4-triazine, 1,2,3-triazine, pyrrole, 2H-pyrrole, 3H-pyrrole, pyrazole, 2H-imidazole, 1,2,3-triazole, 1,2,4-triazole, indole, 3H-indole, 1H-isoindole, cyclopenta(b)pyridine, indazole, quinoline, bisquinoline, isoquinoline, bisisoquinoline, cinnoline, quinazoline, naphthyridine, piperidine, piperazine, pyrrolidine, pyrazolidine, quinuclidine, imidazolidine, picolylimine, purine, benzimidazole, bisimidazole, phenazine, acridine, carbazole, sulfur-containing heterocycles (e.g. thiophene, 1,2-dithiole, 1,3-dithiole, thiepine, benzo(b)thiophene, benzo(c)thiophene, thionaphthene, dibenzothiophene, 2H-thiopyran, 4H-thiopyran, thioanthrene), oxygen-containing heterocycles (e.g. 2H-pyran, 4H-pyran, 2-pyrone, 4-pyrone, 1,2-dioxin, 1,3-dioxin, oxepin, furan, 2H-1-benzopyran, coumarin, coumarone, chromene, chroman-4-one, isochromen-1-one, isochromen-3-one, xanthene, tetrahydrofuran, 1,4-dioxan, dibenzofuran), mixed (e.g. isoxazole, oxazole, thiazole, isothiazole, 1,2,3-oxadiazole, 1,2,4-oxadiazole, 1,3,4-oxadiazole, 1,2,3,4-oxatriazole, 1,2,3,5-oxatriazole, 3H-1,2,3-dioxazole, 3H-1,2-oxathiole, 1,3-oxathiole, 4H-1,2-oxazine, 2H-1,3-oxazine, 1,4-oxazine, 1,2,5-oxathiazine, o-isooxazine, phenoxazine, phenothiazine, pyrano[3,4-b]pyrrole, indoxazine, benzoxazole, anthranil, and morpholine), aromatic nitrogen-containing and oxygen-containing heterocycles, monocyclic N-heteroaryl ligands that are optionally substituted with 1 to 3, preferably 1 or 2, substituents.
The ligand exchange reactions are carried out under inert atmosphere (under nitrogen or argon). The reactions generally are carried out at room temperature or at temperatures from 15° C. to 25° C. or from 25° C. to 60° C., or from 35° C. to 50° C., or from 20° C. to 25° C., or from 30° C. to 40° C., or from 25° C. to 45° C. The reaction times vary from several minutes to several hours 12 hours, 24 hours or 48 hours. Generally the reactions take place in solvents such as tetrahydrofuran (THF), benzene, toluene, xylene, diethyl ether, dioxane, alcohols, methyl-tetrahydrofuran, acetone, ethyl acetate, methyl tert-butyl ether (MTBE), dimethylformamide (DMF), and dichloromethane.
In another embodiment, the invention concerns also processes for synthesizing olefin metathesis catalysts of Formula (B) starting with an olefin metathesis catalyst of Formula (V).
In a typical procedure, as shown in Scheme 3, the sulfoxide ligand of the olefin metathesis catalyst represented by Formula (V) is exchanged with a PRdReORf ligand at room temperature in an inert solvent, such as dichloromethane or toluene, wherein:
R1 is hydrogen;
R2 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally R2 is unsubstituted phenyl, substituted phenyl or substituted 1-propenyl; or R1 and R2 are linked together to form an optionally substituted indenylidene; typically R2 is phenyl, 2-iso-propoxy-phenyl or 2-methyl-1-propenyl; or R1 and R2 are linked together to form 3-phenyl-1-indenylidene;
X1 and X2 are independently halogen, trifluoroacetate, per-fluorophenols or nitrate; generally X1 and X2 are independently Cl, Br, I or F; typically X1 and X2 are independently Cl;
Ra is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally Ra is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Ra is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl;
Rb is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally Rb is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Rb is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl; or Ra and Rb are linked together to form a five or a six heterocyclic membered ring with the sulfoxide group; typically, Ra and Rb are linked together to form a tetrahydrothiophene oxide;
R3 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R3 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl, or C5-C24 aryl substituted with up to three substituents selected from: unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide; typically, R3 is adamantyl, 2,4,6-trimethylphenyl, 2,6-di-iso-propylphenyl, 2-iso-propyl-6-methylphenyl, 2-iso-propyl-phenyl, or 2-methyl-phenyl;
R4 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R4 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl, or C5-C24 aryl substituted with up to three substituents selected from: unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide; typically, R4 is 2,4,6-trimethylphenyl, 2,6-di-iso-propylphenyl, 2-iso-propyl-6-methylphenyl, 2-iso-propyl-phenyl or 2-methyl-phenyl;
Rd is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, substituted C6-C10 aryl, unsubstituted C6-C10 aryl, substituted C3-C8 cycloalkyl or unsubstituted C3-C8 cycloalkyl; generally Rd is unsubstituted C1-C10 alkyl or unsubstituted C6-C10 aryl; typically Rd is phenyl;
Re is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, substituted C6-C10 aryl, unsubstituted C6-C10 aryl, substituted C3-C8 cycloalkyl or unsubstituted C3-C8 cycloalkyl; generally Re is unsubstituted C1-C10 alkyl or unsubstituted C6-C10 aryl; typically Re is phenyl; and
Rf is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, substituted C6-C10 aryl, unsubstituted C6-C10 aryl, substituted C3-C8 cycloalkyl or unsubstituted C3-C8 cycloalkyl; generally Rf is unsubstituted C1-C10 alkyl, unsubstituted C6-C10 aryl or unsubstituted C6-C10 aryl; typically, Rf is phenyl, methyl, p-(OMe)phenyl, iso-propyl or ethyl.
In another embodiment, the invention concerns also processes for synthesizing olefin metathesis catalysts of Formula (C) starting with an olefin metathesis catalyst of Formula (V).
In a typical procedure, as shown in Scheme 4, the sulfoxide ligand of the olefin metathesis catalyst represented by Formula (V) can be exchanged with a PRgORhORi ligand at room temperature in an inert solvent, such as dichloromethane or toluene, wherein:
R1 is hydrogen;
R2 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally R2 is unsubstituted phenyl, substituted phenyl or substituted 1-propenyl; or R1 and R2 are linked together to form an optionally substituted indenylidene; typically R2 is phenyl, 2-iso-propoxy-phenyl or 2-methyl-1-propenyl; or R1 and R2 are linked together to form 3-phenyl-1-indenylidene;
Ra is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally Ra is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Ra is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl;
Rb is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally Rb is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Rb is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl; or Ra and Rb are linked together to form a five or a six heterocyclic membered ring with the sulfoxide group; typically, Ra and Rb are linked together to form a tetrahydrothiophene oxide;
X1 and X2 are independently halogen, trifluoroacetate, per-fluorophenols or nitrate; generally X1 and X2 are independently Cl, Br, I or F; typically X1 and X2 are independently Cl;
R3 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R3 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl, or C5-C24 aryl substituted with up to three substituents selected from: unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide; typically, R3 is adamantyl, 2,4,6-trimethylphenyl, 2,6-di-iso-propylphenyl, 2-iso-propyl-6-methylphenyl, 2-iso-propyl-phenyl or 2-methyl-phenyl;
R4 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R4 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl, or C5-C24 aryl substituted with up to three substituents selected from: unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide; typically, R4 is 2,4,6-trimethylphenyl, 2,6-di-iso-propylphenyl, 2-iso-propyl-6-methylphenyl, 2-iso-propyl-phenyl or 2-methyl-phenyl;
Rg is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, substituted C6-C10 aryl, unsubstituted C6-C10 aryl, substituted C3-C8 cycloalkyl or unsubstituted C3-C8 cycloalkyl; generally Rg is unsubstituted C1-C10 alkyl or unsubstituted C6-C10 aryl; typically Rg is phenyl;
Rh is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, substituted C6-C10 aryl, unsubstituted C6-C10 aryl, substituted C3-C8 cycloalkyl or unsubstituted C3-C8 cycloalkyl; generally Rh is unsubstituted C1-C10 alkyl or unsubstituted C6-C10 aryl; typically Rh is phenyl or methyl; and
Ri is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, substituted C6-C10 aryl, unsubstituted C6-C10 aryl, substituted C3-C8 cycloalkyl or unsubstituted C3-C8 cycloalkyl; generally Ri is unsubstituted C1-C10 alkyl or unsubstituted C6-C10 aryl; typically Ri is phenyl or methyl.
In another embodiment, the invention concerns also processes for synthesizing olefin metathesis catalysts of Formula (D) starting with an olefin metathesis catalyst of Formula (V).
In a typical procedure as shown in Scheme 5, the sulfoxide ligand of the olefin metathesis catalyst represented by Formula (V) is exchanged with a Grubbs-Hoveyda ligand at 60° C. in ethyl acetate, wherein:
R1 is hydrogen;
R2 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally R2 is unsubstituted phenyl, substituted phenyl or substituted 1-propenyl; or R1 and R2 are linked together to form an optionally substituted indenylidene; typically R2 is phenyl, 2-iso-propoxy-phenyl or 2-methyl-1-propenyl; or Rl and R2 are linked together to form 3-phenyl-1-indenylidene;
Ra is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally Ra is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Ra is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl;
Rb is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally Rb is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Rb is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl; or Ra and Rb are linked together to form a five or a six heterocyclic membered ring with the sulfoxide group; typically, Ra and Rb are linked together to form a tetrahydrothiophene oxide;
X1 and X2 are independently halogen, trifluoroacetate, per-fluorophenols or nitrate; generally X1 and X2 are independently Cl, Br, I or F; typically, X1 and X2 are independently Cl;
R3 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R3 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl, or C5-C24 aryl substituted with up to three substituents selected from: unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide; typically, R3 is adamantyl, 2,4,6-trimethylphenyl, 2,6-di-iso-propylphenyl, 2-iso-propyl-6-methylphenyl, 2-iso-propyl-phenyl or 2-methyl-phenyl;
R4 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R4 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl, or C5-C24 aryl substituted with up to three substituents selected from: unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide; typically, R4 is 2,4,6-trimethylphenyl, 2,6-di-iso-propylphenyl, 2-iso-propyl-6-methylphenyl, 2-iso-propyl-phenyl or 2-methyl-phenyl;
Rk is hydrogen, halogen, —NO2, —CN, —CF3, —SO2NRs2, —NHC(O)CF3, —NHC(O)C6F5, —NHC(O)OtBu, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; typically, Rk is hydrogen;
Rl is hydrogen, halogen, —NO2, —CN, —CF3, —SO2NRs2, —NHC(O)CF3, —NHC(O)C6F5, —NHC(O)OtBu, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; typically, Rl is hydrogen;
Rm is hydrogen, halogen, —NO2, —CN, —CF3, —SO2NRs2, —NHC(O)CF3, —NHC(O)C6F5, —NHC(O)OtBu, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; typically, Rm is hydrogen, —NO2, —CN, —CF3, —SO2NRs2, —NHC(O)CF3, —NHC(O)C6F5, or —NHC(O)OtBu; specifically Rm is hydrogen;
Rn is hydrogen, halogen, —NO2, —CN, —CF3, —SO2NRs2, —NHC(O)CF3, —NHC(O)C6F5, —NHC(O)OtBu, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; typically, Rn is hydrogen;
Rs is hydrogen or C1-C6 alkyl; typically Rs is hydrogen, methyl, ethyl or n-propyl; and
Rq is unsubstituted hydrocarbyl, substituted hydrocarbyl; generally, Rq is C1-C10 alkyl; typically, Rq is iso-propyl.
In another embodiment, the invention concerns also processes for synthesizing olefin metathesis catalysts of Formula (E) starting with an olefin metathesis catalyst of Formula (V).
In a typical procedure, as shown in Scheme 6, the sulfoxide ligand of the olefin metathesis catalyst represented by Formula (V) can be exchanged with a P(Rq)3 ligand at room temperature in an inert solvent, such as dichloromethane or toluene, wherein:
R1 is hydrogen;
R2 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally R2 is unsubstituted phenyl, substituted phenyl or substituted 1-propenyl; or R1 and R2 are linked together to form an optionally substituted indenylidene; typically R2 is phenyl, 2-iso-propoxy-phenyl or 2-methyl-1-propenyl; or R1 and R2 are linked together to form 3-phenyl-1-indenylidene;
Ra is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally Ra is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Ra is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl;
Rb is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally Rb is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically Rb is methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, cyclohexyl or phenyl; or Ra and Rb are linked together to form a five or a six heterocyclic membered ring with the sulfoxide group; typically, Ra and Rb are linked together to form a tetrahydrothiophene oxide;
X1 and X2 are independently halogen, trifluoroacetate, per-fluorophenols or nitrate; generally X1 and X2 are independently Cl, Br, I or F; typically X1 and X2 are independently Cl;
R3 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R3 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl, or C5-C24 aryl substituted with up to three substituents selected from: unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide; typically, R3 is adamantyl, 2,4,6-trimethylphenyl, 2,6-di-iso-propylphenyl, 2-iso-propyl-6-methylphenyl, 2-iso-propyl-phenyl or 2-methyl-phenyl;
R4 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R4 is unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl, or C5-C24 aryl substituted with up to three substituents selected from: unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20 heteroalkyl, substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24 alkaryl and halide; typically, R4 is 2,4,6-trimethylphenyl, 2,6-di-iso-propylphenyl, 2-iso-propyl-6-methylphenyl, 2-iso-propyl-phenyl or 2-methyl-phenyl; and
Rp is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, substituted C6-C10 aryl, unsubstituted C6-C10 aryl, substituted C3-C8 cycloalkyl or unsubstituted C3-C8 cycloalkyl; generally Rp is substituted C6-C10 aryl, unsubstituted C6-C10 aryl, substituted C3-C8 cycloalkyl or unsubstituted C3-C8 cycloalkyl; typically Rp is phenyl, cyclohexyl, or cyclopentyl.
At this stage, those skilled in the art will appreciate that many additional compounds that fall under the scope of the invention can be prepared by performing various common chemical reactions. Details of certain specific chemical transformations are provided in the examples.
The metal carbene olefin metathesis catalysts can be utilized in olefin metathesis reactions according to techniques known in the art. For example, the metal carbene olefin metathesis catalysts are typically added to a resin composition as a solid, a solution, or as a suspension. When the metal carbene olefin metathesis catalysts are added to a resin composition as a suspension, the metal carbene olefin metathesis catalysts are suspended in a dispersing carrier such as mineral oil, paraffin oil, soybean oil, tri-iso-propylbenzene, or any hydrophobic liquid which has a sufficiently high viscosity so as to permit effective dispersion of the catalyst(s), and which is sufficiently inert and which has a sufficiently high boiling point so that is does not act as a low-boiling impurity in the olefin metathesis reaction. It will be appreciated that the amount of catalyst that is used (i.e., the “catalyst loading”) in the reaction is dependent upon a variety of factors such as the identity of the reactants and the reaction conditions that are employed. It is therefore understood that catalyst loading can be optimally and independently chosen for each reaction. In general, however, the catalyst will be present in an amount that ranges from a low of about 0.1 ppm, 1 ppm, or 5 ppm, to a high of about 10 ppm, 15 ppm, 25 ppm, 50 ppm, 100 ppm, 200 ppm, 500 ppm, or 1000 ppm relative to the amount of an olefinic substrate (e.g., cyclic olefins).
Resin compositions that may be used with the present invention disclosed herein comprise one or more cyclic olefins. Such cyclic olefins may be optionally substituted, optionally heteroatom-containing, mono-unsaturated, di-unsaturated, or poly-unsaturated C5 to C24 hydrocarbons that may be mono-, di-, or poly-cyclic. The cyclic olefin may generally be any strained or unstrained cyclic olefin, provided the cyclic olefin is able to participate in a ROMP reaction either individually or as part of a ROMP cyclic olefin composition.
Examples of bicyclic and polycyclic olefins thus include, without limitation, dicyclopentadiene (DCPD); trimer and other higher order oligomers of cyclopentadiene including without limitation tricyclopentadiene (cyclopentadiene trimer), cyclopentadiene tetramer, and cyclopentadiene pentamer; ethylidenenorbornene; dicyclohexadiene; norbornene; C2-C12 hydrocarbyl substituted norbornenes; 5-butyl-2-norbornene; 5-hexyl-2-norbornene; 5-octyl-2-norbornene; 5-decyl-2-norbornene; 5-dodecyl-2-norbornene; 5-vinyl-2-norbornene; 5-ethylidene-2-norbornene; 5-isopropenyl-2-norbornene; 5-propenyl-2-norbornene; 5-butenyl-2-norbornene; 5-tolyl-norbornene; 5-methyl-2-norbornene; 5-ethyl-2-norbornene; 5-isobutyl-2-norbornene; 5,6-dimethyl-2-norbornene; 5-phenylnorbornene; 5-benzylnorbornene; 5-acetylnorbornene; 5-methoxycarbonylnorbornene; 5-ethyoxycarbonyl-1-norbornene; 5-methyl-5-methoxy-carbonylnorbornene; bicyclo[2.2.1]hept-2-ene-2-carboxylic acid, 2-ethylhexyl ester; 5-cyanonorbornene; 5,5,6-trimethyl-2-norbornene; cyclo-hexenylnorbornene; endo, exo-5,6-dimethoxynorbornene; endo, endo-5,6-dimethoxynorbornene; endo, exo-5,6-dimethoxy carbonylnorbornene; endo,endo-5,6-dimethoxycarbonylnorbornene; 2,3-dimethoxynorbornene; norbornadiene; tricycloundecene; tetracyclododecene; 8-methyl tetracyclododecene; 8-ethyltetracyclododecene; 8-methoxy carbonyltetracyclo dodecene; 8-methyl-8-tetra cyclododecene; 8-cyanotetracyclo dodecene; pentacyclopentadecene; pentacyclo hexadecene; bicyclo[2.2.1]hept-2-ene-5-phenoxymethyl; 2-ethylhexyl ester-bicyclo[2.2.1]hept-5-ene-2-carboxylic acid; 2-hydroxyethyl ester-bicyclo[2.2.1]hept-5-ene-2-carboxylic acid; bicyclo[2.2.1]hept-5-ene-2-methanol; bicyclo[2.2.1]hept-5-ene-2-heptanoic acid-methyl ester; bicyclo[2.2.1]hept-5-ene-2-hexanoic acid-methyl ester; 1,4:5,8-dimethanonaphthalene, 2-hexyl-1,2,3,4,4a,5,8,8a-octahydro; bicyclo[2.2.1]hept-5-ene-2-octanoic acid-methyl ester; 1,4:5,8-dimethano naphthalene; 2-butyl-1,2,3,4,4a,5,8,8a-octahydro; ethylidenetetracyclododecene; 2-vinyl-1,2,3,4,4a,5,8,8a-octahydro-1,4:5,8-dimethano naphthalene; and the like, and their structural isomers, stereoisomers, and mixtures thereof.
In the following examples, efforts have been made to ensure accuracy with respect to numbers used (e.g., amounts, temperature, etc.) but some experimental error and deviation should be accounted for. The examples are to be considered as not being limiting of the invention described herein. Surprisingly, the olefin metathesis catalysts of the invention were obtained only in the cis configuration, no traces of the trans stereoisomers were detected.
All reactions involving metal complexes were conducted in oven-dried glassware under an argon or nitrogen atmosphere using standard Schlenk techniques. Chemicals and solvents were obtained from Sigma-Aldrich, Strem, Alfa Aesar, Nexeo, Brenntag, AG Layne and TCI. Commercially available reagents were used as received unless otherwise noted. Silica gel was purchased from Fisher (0.040-0.063 μm, EMD Millipore).
The crystallographic measurements were performed at 100(2) K using a Bruker APEX-II CCD area detector diffractometer (Mo—Kα radiation, λ=0.71073 Å). In each case, a specimen of suitable size and quality was selected and mounted onto a nylon loop. The structures were solved by direct methods, which successfully located most of the non-hydrogen atoms. Semi-empirical absorption corrections were applied. Subsequent refinement on F2 using the SHELXTL/PC package (version 6.1) allowed location of the remaining non-hydrogen atoms.
Ultrene® 99 dicyclopentadiene (DCPD) was obtained from Cymetech Corporation. A modified DCPD base resin containing 20-25% tricyclopentadiene (and small amounts of higher cyclopentadiene homologs) (DCPD-HT) was prepared by heat treatment of Ultrene® 99 DCPD generally as described in U.S. Pat. No. 4,899,005.
Catalysts C931, C933, C793, C827, C705, C727, C748 and C848 were prepared using known methods.
1H and 13C NMR spectra were recorded on a Varian 400 MHz spectrometer. Chemical shifts are reported in ppm downfield from Me4Si by using the residual solvent peak as an internal standard (CDCl3 δ 7.24 ppm). Spectra were analyzed and processed using MestReNova software.
General GC method conditions: injection temperature, 250° C.; detector temperature, 280° C.; oven temperature, starting temperature, 100° C.; hold time, 1 min. The ramp rate was 10° C./min to 250° C., hold time 12 min; carrier gas helium.
GC Method 1: Column: DB-225, 30 m×0.25 mm (ID)×0.25 μm film thickness. Manufacturer: Agilent; GC and column conditions: Injector temperature: 220° C., Detector temperature: 220° C.; Oven temperature: Starting temperature: 35° C., hold time: 0.5 minutes.
Ramp rate 10° C./min to 130° C., hold time: 0 minutes. Ramp rate 20° C./min to 220° C., hold time: 5 minutes. Carrier gas: Helium. Mean gas velocity: 25 cm/sec. Split ratio: 20:1.
The following abbreviations are used in the examples:
To a 20 mL scintillation vial equipped with a magnetic stir bar were added C931 (0.500 g, 0.537 mmol), p-toluenesulfonyl chloride (0.051 g, 0.268 mmol), dimethyl sulfoxide (0.210 g, 2.68 mmol), and dichloromethane (4 mL). The reaction was stirred for one hour then filtered through a plug of celite and combined with diethyl ether (30 mL). The resulting black precipitate was isolated by filtration, washed with diethyl ether (2×10 mL) then dried in vacuum to afford C747 as a black powder (0.346 g, 86.3% yield). The X-ray structure of C747 is shown in
1H NMR (400 MHz, CDCl3): δ 8.68 (d, J=7.4 Hz, 1H), 7.71 (d, J=7.6 Hz, 2H), 7.52 (t, J=7.1 Hz, 1H), 7.42 (t, J=7.5 Hz, 2H), 7.31 (t, J=7.4 Hz, 1H), 7.25 (t, J=7.1 Hz, 1H), 7.11 (d, J=6.1 Hz, 2H), 7.04 (d, J=7.0 Hz, 1H), 6.86 (s, 1H), 6.26 (d, J=3.8 Hz, 2H), 4.13-3.99 (m, 1H), 3.99-3.80 (m, 2H), 3.80-3.69 (m, 1H), 2.82 (s, 3H), 2.69 (s, 3H), 2.68 (s, 3H), 2.41 (s, 3H), 2.35 (s, 3H), 2.11 (s, 3H), 2.05 (s, 3H), 1.77 (s, 3H).
To a 40 mL scintillation vial equipped with a magnetic stir bar were added C848 (0.500 g, 0.589 mmol), p-toluenesulfonyl chloride (0.056 g, 0.30 mmol), dimethyl sulfoxide (0.230 g, 2.94 mmol), and dichloromethane (4 mL). The reaction was stirred at ambient temperature for one hour then filtered through a plug of celite and combined with diethyl ether (30 mL). The resulting purple precipitate was isolated by filtration, washed with diethyl ether (2×10 mL) then dried in vacuum to afford C647m as a purple crystalline solid (0.269 g, 70.7% yield). The X-ray structure of C647m is shown in
1H NMR (400 MHz, C6D6) δ 16.03 (s, 1H), 8.15 (d, J=25.0 Hz, 2H), 7.21 (t, J=7.3 Hz, 1H), 7.00 (t, J=7.8 Hz, 2H), 6.84 (s, 1H), 6.75 (s, 1H), 6.65 (s, 1H), 6.17 (s, 1H), 3.33-3.00 (m, 4H), 2.87 (s, 3H), 2.67 (s, 3H), 2.61 (s, 3H), 2.22 (s, 3H), 2.14 (s, 3H), 2.07 (s, 3H), 2.04 (s, 3H), 1.98 (s, 3H).
To a 40 mL scintillation vial equipped with a magnetic stir bar were added C933 (0.500 g, 0.536 mmol), p-toluenesulfonyl chloride (0.051 g, 0.27 mmol), dimethyl sulfoxide (0.209 g, 2.68 mmol), and ethyl acetate (10 mL). The reaction was stirred at ambient temperature for three hours affording a fine blue-gray precipitate. The solid was isolated by filtration, washed with ethyl acetate (2×5 mL) then dried in vacuum to afford C731 as a blue-gray solid (0.148 g, 37.8% yield).
1H NMR (400 MHz, C6D6): δ 16.16 (s, 1H), 7.99 (s, 2H), 7.31-7.01 (m, 6H), 6.94 (t, J=7.2 Hz, 2H), 6.65 (d, J=7.2 Hz, 1H), 4.63-4.48 (m, 1H), 4.07-3.92 (m, 1H), 3.76-3.60 (m, 2H), 3.60-3.44 (m, 3H), 3.42-3.27 (m, 1H), 1.97 (s, 3H), 1.87 (d, J=6.0 Hz, 3H), 1.72 (s, 3H), 1.67 (d, J=6.7 Hz, 3H), 1.65 (d, J=6.8 Hz, 3H), 1.20 (d, J=6.3 Hz, 3H), 1.12 (d, J=6.3 Hz, 3H), 1.04 (d, J=6.1 Hz, 3H), 0.88 (d, J=6.5 Hz, 3H), 0.77 (d, J=5.7 Hz, 3H).
To a 40 mL scintillation vial equipped with a magnetic stir bar were added C793 (0.500 g, 0.631 mmol), p-toluenesulfonyl chloride (0.060 g, 0.32 mmol), dimethyl sulfoxide (0.246 g, 3.15 mmol), and methyl tert-butyl ether (10 mL). The reaction was stirred at ambient temperature for four hours affording a purple precipitate. The solid was isolated by filtration then recrystallized from dichloromethane and diethyl ether. The resulting purple crystals were isolated by filtration, washed with diethyl ether (2×5 mL) then dried in vacuum to afford C591 as a purple crystalline solid (0.234 g, 62.7% yield). Two isomers [87:13], which are not stereoisomers, were observed in solution.
1H NMR (400 MHz, CD2Cl2, major isomer) δ 15.82 (s, 1H), 8.72 (d, J=7.7 Hz, 1H), 7.78 (d, J=7.5 Hz, 2H), 7.56 (dd, J=16.6, 8.1 Hz, 2H), 7.52-7.39 (m, 2H), 7.24 (t, J=7.9 Hz, 3H), 7.15 (d, J=7.9 Hz, 1H), 6.96 (t, J=7.5 Hz, 1H), 6.45 (t, J=7.6 Hz, 1H), 4.59-4.47 (m, 1H), 4.22 (q, J=10.1 Hz, 1H), 3.90 (q, J=10.4 Hz, 1H), 3.83-3.72 (m, 1H), 2.67 (s, 3H), 2.59 (s, 3H), 2.29 (s, 3H), 1.90 (s, 3H).
1H NMR (400 MHz, CD2Cl2, minor isomer, selected resonances) δ 16.02 (s, 1H), 8.91 (d, J=7.7 Hz, 1H), 7.73 (d, J=7.6 Hz, 3H), 6.90-6.84 (m, 1H), 4.43-4.34 (m, 1H), 2.40 (s, 3H), 2.01 (s, 3H), 1.96 (s, 3H).
To a 40 mL scintillation vial equipped with a magnetic stir bar were added C827 (0.500 g, 0.605 mmol), p-toluenesulfonyl chloride (0.058 g, 0.30 mmol), dimethyl sulfoxide (0.236 g, 3.02 mmol), and methyl tert-butyl ether (10 mL). The reaction was stirred at ambient temperature for twenty four hours and the resulting brown precipitate was isolated by filtration, washed with methyl tert-butyl ether (2×10 mL) then dried in vacuum to afford C625 as a light brown solid (0.298 g, 78.8% yield).
1H NMR (400 MHz, CDCl3) δ 16.10 (d, J=11.3 Hz, 1H), 7.83 (d, J=11.2 Hz, 1H), 7.08 (s, 1H), 7.05 (s, 1H), 6.82 (s, 1H), 6.73 (s, 1H), 4.13-4.00 (m, 1H), 4.00-3.78 (m, 3H), 2.73 (s, 6H), 2.55 (s, 3H), 2.54 (s, 3H), 2.38 (s, 3H), 2.32 (s, 3H), 2.22 (s, 6H), 1.33 (s, 3H), 1.27 (s, 3H).
To a 40 mL scintillation vial equipped with a magnetic stir bar was added C931 (0.500 g, 0.537 mmol), p-toluenesulfonyl chloride (0.051 g, 0.27 mmol), tetrahydrothiophene 1-oxide (0.279 g, 2.68 mmol), and toluene (5 mL). The reaction was stirred at ambient temperature for two hours then diluted with diethyl ether (15 mL). The precipitate was isolated by filtration, washed with diethyl ether (2×20 mL) followed by hexanes (1×20 mL) then dried in vacuum to afford C865 (0.418 g, 90.0% yield).
1H NMR (400 MHz, CDCl3) δ 8.72 (d, J=7.2 Hz, 1H), 7.71 (d, J=7.7 Hz, 2H), 7.52 (t, J=7.3 Hz, 1H), 7.42 (t, J=7.5 Hz, 2H), 7.33-7.20 (m, 4H), 7.20-7.14 (m, 3H), 7.11 (d, J=8.9 Hz, 2H), 7.04 (d, J=7.0 Hz, 1H), 6.93 (s, 1H), 6.28 (s, 2H), 4.15-4.03 (m, 1H), 4.03-3.86 (m, 2H), 3.84-3.71 (m, 1H), 2.92-2.85 (m, 2H), 2.84 (s, 3H), 2.69 (s, 3H), 2.70-2.60 (m, 1H), 2.43 (s, 3H), 2.36 (s, 3H), 2.35 (s, 3H), 2.09 (s, 3H), 2.15-2.04 (m, 1H), 2.04-1.90 (m, 2H), 1.78 (s, 3H), 1.82-1.73 (m, 2H).
To a 40 mL scintillation vial equipped with a magnetic stir bar was added C931 (0.500 g, 0.537 mmol), p-toluenesulfonyl chloride (0.051 g, 0.27 mmol), tetrahydrothiophene 1-oxide (0.279 g, 2.68 mmol), and ethyl acetate (5 mL). The reaction was stirred at ambient temperature for three hours then diluted with diethyl ether (25 mL). The precipitate was isolated by filtration, washed with diethyl ether (2×10 mL) followed by hexanes (1×20 mL) then dried in vacuum to afford C861 (0.386 g, 83.5% yield).
1H NMR (400 MHz, CDCl3) δ 8.71 (d, J=7.2 Hz, 1H), 7.70 (d, J=7.7 Hz, 2H), 7.51 (t, J=7.2 Hz, 1H), 7.41 (t, J=7.4 Hz, 2H), 7.33-7.19 (m, 2H), 7.11 (d, J=8.1 Hz, 2H), 7.03 (d, J=7.1 Hz, 1H), 6.92 (s, 1H), 6.27 (s, 2H), 4.11 (dd, J=14.3, 7.1 Hz, 2H), 4.15-4.02 (m, 1H), 4.03-3.85 (m, 2H), 3.84-3.71 (m, 1H), 2.92-2.79 (m, 2H), 2.83 (s, 3H), 2.68 (s, 3H), 2.70-2.59 (m, 1H), 2.42 (s, 3H), 2.35 (s, 3H), 2.08 (s, 3H), 2.15-2.07 (m, 1H), 2.03 (s, 3H), 2.02-1.90 (m, 2H), 1.77 (s, 3H), 1.82-1.73 (m, 2H), 1.25 (t, J=7.1 Hz, 3H).
To a 40 mL scintillation vial equipped with a magnetic stir bar was added C931 (0.500 g, 0.537 mmol), p-toluenesulfonyl chloride (0.051 g, 0.27 mmol), tetrahydrothiophene 1-oxide (0.279 g, 2.68 mmol), and dichloromethane (4 mL). The reaction was stirred at ambient temperature for three hours then diluted with diethyl ether (30 mL). The precipitate was isolated by filtration, washed with diethyl ether (2×10 mL) followed by hexanes (1×20 mL) then dried in vacuum to afford C773 (0.345 g, 83.0% yield).
1H NMR (400 MHz, CDCl3) δ 8.71 (d, J=7.1 Hz, 1H), 7.71 (d, J=7.6 Hz, 2H), 7.52 (t, J=7.1 Hz, 1H), 7.42 (t, J=7.4 Hz, 2H), 7.34-7.19 (m, 2H), 7.11 (d, J=8.0 Hz, 2H), 7.03 (d, J=7.0 Hz, 1H), 6.92 (s, 1H), 6.28 (s, 2H), 4.14-4.03 (m, 1H), 4.03-3.86 (m, 2H), 3.82-3.72 (m, 1H), 2.83 (s, 3H), 2.91-2.79 (m, 2H), 2.69 (s, 3H), 2.72-2.60 (m, 1H), 2.42 (s, 3H), 2.36 (s, 3H), 2.18-2.04 (m, 1H), 2.08 (s, 3H). 2.04-1.88 (m, 2H), 1.77 (s, 3H), 1.82-1.73 (m, 2H).
To a 40 mL scintillation vial equipped with a magnetic stir bar was added C848 (0.500 g, 0.589 mmol), p-toluenesulfonyl chloride (0.056 g, 0.30 mmol), tetrahydrothiophene 1-oxide (0.307 g, 2.94 mmol), and dichloromethane (4 mL). The reaction was stirred at ambient temperature for one hour then diluted with diethyl ether (25 mL). The precipitate was isolated by filtration, washed with diethyl ether (2×10 mL) followed by hexanes (1×15 mL) then dried in vacuum to afford C673 (0.248 g, 62.6% yield).
1H NMR (400 MHz, CDCl3) δ 16.12 (s, 1H), 7.82 (d, J=7.7 Hz, 2H), 7.55 (t, J=7.2 Hz, 1H), 7.23 (t, J=7.7 Hz, 2H), 7.11 (br s, 2H), 6.93 (s, 1H), 6.29 (s, 1H), 4.11-3.94 (m, 3H), 3.86-3.76 (m, 1H), 2.72 (s, 3H), 2.69 (s, 3H), 2.64 (s, 3H), 2.62-2.45 (m, 3H), 2.35 (s, 3H), 2.27-2.17 (m, 1H), 2.15 (s, 3H), 2.07 (s, 3H), 2.05-1.91 (m, 2H), 1.84-1.68 (m, 2H).
To a 40 mL scintillation vial equipped with a magnetic stir bar was added C827 (0.500 g, 0.605 mmol), p-toluenesulfonyl chloride (0.058 g, 0.30 mmol), tetrahydrothiophene 1-oxide (0.315 g, 3.02 mmol), and ethyl acetate (5 mL). The reaction was stirred at ambient temperature for 16 hours. The precipitate was isolated by filtration and recrystallized from dichloromethane/methanol at −30° C. The resulting purple crystalline product was isolated by filtration, washed with dichloromethane/methanol (1:10, 2×5 mL) then dried in vacuum to afford C651 (0.141 g, 35.7% yield).
1H NMR (400 MHz, CDCl3) δ 16.73 (d, J=11.3 Hz, 1H), 7.66 (d, J=11.5 Hz, 1H), 7.09 (s,1H), 7.05 (s, 1H), 6.83 (s, 1H), 6.71 (s, 1H), 4.17-4.02 (m, 1H), 4.01-3.84 (m, 3H), 3.16-3.06 (m, 1H), 3.02-2.89 (m, 1H), 2.85-2.74 (m, 2H), 2.75 (s, 3H), 2.59 (s, 3H), 2.54 (s, 3H), 2.33 (s, 6H), 2.22 (s, 3H), 2.14-2.02 (m, 2H), 1.99-1.83 (m, 2H), 1.34 (s, 3H), 1.26 (s, 3H).
To a 40 mL scintillation vial equipped with a magnetic stir bar was added C931 (0.500 g, 0.537 mmol), p-toluenesulfonyl chloride (0.051 g, 0.27 mmol), dibutyl sulfoxide (0.436 g, 2.69 mmol), and diethyl ether (10 mL). The reaction was stirred at ambient temperature for twelve hours. The precipitate was isolated by filtration, washed with diethyl ether (1×10 mL) followed by hexanes (1×20 mL) then dried in vacuum to afford C831m (0.195 g, 43.7% yield).
1H NMR (400 MHz, CD2Cl2) δ 8.68-8.60 (m, 1H), 7.77-7.69 (m, 2H), 7.57-7.50 (m, 1H), 7.44 (t, J=7.5 Hz, 2H), 7.35-7.28 (m, 2H), 7.15 (s, 1H), 7.13 (dd, J=5.6, 2.7 Hz, 1H), 7.07 (s, 1H), 6.77 (s, 1H), 6.36 (s, 1H), 6.21 (s, 1H), 4.06-3.95 (m, 1H), 3.94-3.81 (m, 2H), 3.78-3.65 (m, 1H), 2.94 (ddd, J=14.5, 12.3, 5.6 Hz, 1H), 2.77 (s, 3H), 2.70 (s, 3H), 2.64-2.51 (m, 1H), 2.47 (s, 3H), 2.36 (s, 3H), 1.95 (s, 3H), 1.73 (s, 3H), 1.71-1.60 (m, 1H), 1.60-1.43 (m, 2H), 1.33-1.19 (m, 2H), 1.19-1.03 (m, 2H), 0.98-0.91 (m, 2H), 0.88 (t, J=7.2 Hz, 3H), 0.83-0.70 (m, 1H), 0.48 (t, J=7.3 Hz, 3H).
To a 40 mL scintillation vial equipped with a magnetic stir bar was added C747 (0.590 g, 0.790 mmol), (3,6-dichlorobenzene-1,2-dithiolato)(ethylenediamine)zinc(II) (0.291 g, 0.869 mmol), and tetrahydrofuran (8 mL). The reaction was stirred at ambient temperature for one hour then concentrated to dryness. The resulting residue was extracted with dichloromethane (10 mL), filtered through a plug of celite, and then concentrated in vacuum to about 5 mL. Slow addition of hexanes (30 mL) with rapid stirring afforded a precipitate that was isolated by filtration, washed with hexanes (2×10 mL) then dried in vacuum to afford C885ss (0.604 g, 86.4% yield) as a dark purple powder.
1H NMR (400 MHz, CD2Cl2) δ 7.76 (d, J=7.3 Hz, 2H), 7.55-7.40 (m, 3H), 7.31 (br s, 1H), 7.20 (br s, 1H), 7.12 (br s, 1H), 7.04 (t, J=7.3 Hz, 2H), 6.97 (d, J=6.7 Hz, 1H), 6.84 (br s, 1H), 6.74 (t, J=7.2 Hz, 1H), 6.31 (d, J=7.6 Hz, 2H), 6.19 (br s, 1H), 4.03 (br s, 1H), 3.92 (br s, 3H), 2.90 (br s, 3H), 2.64 (br s, 3H), 2.43 (br s, 6H), 2.26 (br s, 6H), 2.18 (br s, 3H), 1.78 (br s, 3H).
To a 40 mL scintillation vial equipped with a magnetic stir bar was added C647 (0.300 g, 0.464 mmol), (3,6-dichlorobenzene-1,2-dithiolato)(ethylenediamine) zinc(II) (0.171 g, 0.510 mmol), and tetrahydrofuran (5 mL). The reaction was stirred at ambient temperature for thirty minutes then concentrated to dryness. The resulting residue was extracted with dichloromethane (20 mL), passed through a 0.2 μm syringe filter, and then concentrated in vacuum to ca. 4 mL. Diethyl ether (30 mL) was added slowly affording a green microcrystalline precipitate. The product was isolated by filtration, washed with diethyl ether (2×5 mL) and dried in vacuum to afford C785ss (0.283 g, 77.8% yield).
1H NMR (400 MHz, CD2Cl2) δ 14.77 (s, 1H), 7.28 (t, J=7.3 Hz, 1H), 7.18 (d, J=8.1 Hz, 1H), 7.10 (d, J=8.2 Hz, 1H), 7.06 (s, 1H), 6.90-6.81 (m, 4H), 6.47 (d, J=7.3 Hz, 2H), 6.23 (s, 1H), 4.10-3.90 (m, 4H), 2.71 (s, 3H), 2.68 (s, 3H), 2.66 (s, 3H), 2.35 (s, 3H), 2.30 (s, 3H), 2.28 (s, 3H), 2.21 (s, 3H), 2.02 (s, 3H).
To a 20 mL scintillation vial equipped with a magnetic stir bar were added C747 (0.500 g, 0.670 mmol), (PhO)PPh2 ([CAS 13360-92-4] 0.196 g, 0.703 mmol), and dichloromethane (5 mL). The reaction was stirred at ambient temperature for one hour then concentrated to 1 mL under vacuum. Hexanes (14 mL) was added and the resulting precipitate was isolated by filtration, washed with hexanes (2×10 mL) then dried in vacuum to afford C947 as a red-brown powder (0.599 g, 94.5% yield). The 1H NMR data correspond to the data found in the literature.
To a 20 mL scintillation vial equipped with a magnetic stir bar were added C747 (0.500 g, 0.670 mmol), 2-isopropoxy-P-methylstyrene (0.153 g, 0.870 mmol), heptanes (5 mL), and methanol (1 mL). The reaction was stirred at 60° C. for two hours then cooled to ambient temperature. The resulting precipitate was isolated by filtration, washed with methanol (2×5 mL) then dried in vacuum to afford C627 as a green solid (0.332 g, 79.1% yield). The 1H NMR data correspond to the data found in the literature.
To a 20 mL scintillation vial equipped with a magnetic stir bar were added C647m (0.400 g, 0.619 mmol), 2-isopropoxy-β-methylstyrene (0.142 g, 0.804 mmol), heptanes (5 mL), and methanol (1 mL). The reaction was stirred at 60° C. for one hour then cooled to ambient temperature. The resulting precipitate was isolated by filtration, washed with methanol (2×5 mL) then dried in vacuum to afford C627 as a green solid (0.228 g, 58.9% yield). The 1H NMR data correspond to the data found in the literature.
To a 20 mL scintillation vial was added C747 (0.300 g, 0.402 mmol), internal olefin [stilbene or β-methylstyrene] (3.6-10 equiv), and halogenated solvent (chloroform or dichloromethane, 4 mL). Reactions were heated at 40 or 60° C. with stirring until <5% C747 remained as determined by 1H NMR spectroscopy (2 to 24 hours). PCy3 (0.124 g, 0.442 mmol) was subsequently added and the reaction stirred for an additional 30 minutes. Yields of C848 ranged from 50-80% as judged by 1H and 31P NMR spectroscopy. The 1H NMR data correspond to the data found in the literature.
The catalytic activity of the complexes according to the invention was evaluated in ROMP reactions as follows. A 250 mL beaker was filled with 100 g of DCPD-HT monomer and 50 ppm of CHP. The monomer was equilibrated to the desired temperature in an oil bath (30° C.+/−0.5° C.). A J-Type thermocouple was suspended directly into the center of the monomer. The catalyst under study was dissolved in solvent (either toluene or CH2Cl2) to form a catalyst solution and the catalyst solution was then added to the monomer at a molar ratio of 45,000:1 (monomer:catalyst) to form a ROMP composition. Addition of the catalyst to the monomer to form the ROMP composition denoted the start of the ROMP reaction and hence, this was time point zero. Temperature readings were recorded using the thermocouple. The exotherm time was determined by measuring the amount of time that passed (i.e., the time difference) between time point zero and the time point that a propagating interface of the ROMP composition was first visually observed as the ROMP composition transitioned from a liquid state or gel state to a cured polymer state. ROMP reactions were stopped 2 hours after addition of the catalyst solution to the monomer. Time to exotherm is expressed by: slow>120 minutes; moderate 30-120 minutes; medium 1-<30 minutes; fast<1 minute and peak exotherm temperature. The results are shown in Table (5).
Following the procedure outlined in Organometallics, 2006, 25, 5740-5745, inside an argon filled glovebox, a screwcap NMR tube fitted with a PTFE septum was charged with CD2Cl2 (0.75 mL or 0.775 mL) and catalyst stock solution (0.016 M, 50 μL, 0.80 μmol, 1.0 mol % or 0.016 M, 25 μL, 0.80 μmol, 0.5 mol %). Samples were equilibrated to 30° C. in a preheated NMR probe before diethyl 2,2-diallylmalonate (19.3 μL, 19.2 mg, 0.080 mmol, 0.1 M) was added via syringe. The ensuing reaction was monitored for 30 minutes using the Varian array function and the conversion to diethyl cyclopent-3-ene-1,1-dicarboxylate was determined by comparing the ratio of the integrals of the methylene protons in the starting material, δ 2.61 (dt), with those in the product, δ 2.98 (s).
In an argon filled glovebox, a 4 mL scintillation vial equipped with a magnetic stir bar was charged with C785ss (0.0046 g, 0.0059 mmol) and tetrahydrofuran (0.5 mL). cis-5-Tetradecene (0.150 mL total, 0.588 mmol) was subsequently added, the vial was sealed and stirred at 40° C. The reaction was sampled at appropriate time intervals and yields/stereoselectivies were determined by gas chromatography (Method 1) as shown in Table (6).
This application claims the benefit of U.S. Provisional Patent Application No. 62/378,791, filed Aug. 24, 2016.
| Number | Date | Country | |
|---|---|---|---|
| 62378791 | Aug 2016 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 16327566 | Feb 2019 | US |
| Child | 17358718 | US |
